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ABSTRACT 
Background: The prevalence of diabetes has been steadily increasing for the past 
three decades. Many factors including personal, social, and environmental factors 
influence on the onset and progression of the disease. There is a significant evidence 
suggest metabolic consequences of stress in an individual suffering from chronic 
disease like diabetes mellitus. Researches on pranayama, demonstrated its ability to 
regulate autonomic functions and metabolic consequences brought about by the stress. 
Previous study on various pranayama in healthy individual has shown improvement in 
fasting and post-prandial blood glucose level. 
Aim: To evaluate and compare the effects of Bhastrika and Kapalbhati Pranayama on 
blood glucose level in subjects with type 2 diabetes mellitus; A prospective pre-post 
study design. 
Methodology: Fifty subjects aged between 30 – 55 years, pre-diagnosed with Type 2 
Diabetes Mellitus, who satisfy inclusion and exclusion criteria were recruited from the 
Out Patients Department of Government Yoga and Naturopathy Medical College and 
Hospital, Chennai. They were randomized to two groups. Group A (n=25) practiced 
Bhastrika Pranayama and Group B (n=25) practiced Kapalbhati Pranayama for five 
weeks (30 days practice with break of a day after every 6 days). The Fasting Blood 
Glucose (FBG) and 2-hr Post-Prandial Blood Glucose (PPBG) were estimated on day 
1 (baseline data) and day 30 (end-point data). The collected data were properly 
maintained and statistically analyzed using “paired‘t’ test” and “two-sample‘t’ test” 
with Stats 9.0 (College, Station, Texas, USA). 
XVI 
 
Result: The result demonstrates a statistically significant change in both fasting blood 
glucose (FBG) and post-prandial blood glucose (PPBG) level in subjects of both 
Groups (Bhastrika and Kapalbhati group). The overall comparison between the groups 
revealed that the practice of bhastrika pranyama generated better outcome, compared 
to those practiced kapalbhati pranayama. 
Conclusion: Present study findings suggest that the practice of Bhastrika as well as 
kapalbhati pranayama found to be effective in improving the biochemical parameters 
viz. fasting blood glucose and post-prandial blood glucose of type 2 diabetes mellitus. 
Hence, the practice of pranayama can be implemented in the management of diabetes. 
Further study of longer duration and large number of samples is necessary to reaffirm 
the assertion. 
Keywords: Type 2 Diabetes Mellitus, Bhastrika Pranayama, Kapalbhati Pranayama, 
Fasting Blood Glucose, Post-Prandial Blood Glucose.  
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1.0 INTRODUCTION 
 
Diabetes Mellitus (DM) refers to a group of common metabolic disorders that share 
the phenotype of hyperglycemia. (Kasper et al., 2015) Chronic hyperglycemic state 
presents with disturbances of carbohydrate, protein and fat metabolism, occurs either 
due to inadequate secretion of insulin (a hormone which control blood glucose level 
and prevents hyperglycemia) or when the body cannot effectively use the insulin 
produced by beta cells of the pancreatic islets. (World Health Organization, 1999) 
 
Diabetes prevalence has been rising more rapidly in middle- and low-income 
countries. Global prevalence of diabetes among adults over 18 years of age has risen 
from 4.7% in 1980 to 8.5% in 2014. The number of people with diabetes has risen 
from 108 million in 1980 to 422 million in 2014. In 2015, an estimated 1.6 million 
deaths were directly caused by diabetes. Diabetes can be treated and its consequences 
may be avoided / delayed with proper diet, physical activity, medication, regular 
screening and treatment of complications. (World Health Organization, 2016)  
 
Type 2 diabetes (formerly called non-insulin dependent/adult onset diabetes) arises as 
a result of body’s ineffective use of insulin, almost always with a major contribution 
from insulin resistance. (World Health Organization, 1999) Symptoms of type 2 
diabetes mellitus may be similar to that of type 1 diabetes, but are often less marked or 
absent. Because of this, the disease may go undiagnosed for several years, until 
complication arises. (World Health Organization, 2016) 
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The pathogenesis of type 2 diabetes is thought to begin with lifestyle-induced insulin 
resistance, which gradually increases demand on pancreatic beta cells to secrete 
insulin. (Swisa et al., 2017) 
 
Type 2 diabetes mellitus is a chief concern for patients, health care providers and 
health care systems in America, and around the globe. Individuals with type 2 diabetes 
mellitus exhibit clinical and subclinical symptoms of anxiety more frequently than 
people without diabetes. Anxiety is traditionally associated with poor metabolic 
outcomes and increased medical complications among those with type 2 diabetes 
mellitus. Hence it is proposed link between anxiety and diabetes; offer an innovative 
and evidence based collaborative care for anxiety and diabetes in primary care. 
(Bickett & Tapp, 2016) 
 
Stress has long been shown to have major effects on metabolic activity. It is a 
potential contributor to chronic hyperglycemia in diabetes. Although human studies 
on the role of stress in the onset and course of type 2 diabetes are few, there are more 
consistent evidence supports the role of stress in type 2 diabetes mellitus. 
Furthermore, there is mounting evidence of autonomic contributions to the patho-
physiology of type 2 diabetes mellitus both in animals and humans. (Surwit et al., 
1992) 
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Mood affects food intake: Depression and/or anxiety are risk factors for the 
development of diabetes (Bystritsky et al., 2014) (Ljubičić et al., 2013) and vice 
versa. (Guedes et al., 2013) (Ali et al., 2013) Those patients who had family support 
or had close relationship with their physician, those who are knowledgeable towards 
diabetes and those with better confidence in ability to manage self care behaviors had 
a lower level (better control) of HbA1c. In contrast, patients with depression or stress 
were significantly correlated with poor glycemic control. Hence, effective and tailored 
interventions were needed to mitigate exposure to these risk factors, as this would 
improve better glycemic control and reduce the risks of diabetes complications. 
(Badedi et al., 2016) 
 
Today’s clinicians are presented with an extensive range of oral anti-diabetic drugs for 
type 2 diabetes. Tailoring the treatment to the individual patient is an important 
principle. Neither sulphonylureas nor biguanides are able to appreciably alter the rate 
of progression of hyperglycemia in patients with type 2 diabetes. Preliminary data 
suggesting that thiazolidinediones may provide better long-term glycaemic stability 
are currently being tested in clinical trials; current evidence, while encouraging, is not 
conclusive. However, intensive lifestyle intervention can be more effective than drug 
therapy; No anti-diabetic drugs are presently licensed for use in pre-diabetic 
individuals. (Krentz & Bailey, 2005) 
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Despite, implementation of interventions based on traditional risk factors, the 
incidence of diabetes continues to rise. Identifying additional factors that contribute to 
increased risk is of public health significance. It has been estimated that as much as 
60% type 2 diabetes risks is due to modifiable environmental factors including 
obesity, physical inactivity, diet quality, smoking, hypertension and abnormal 
cholesterol levels. (Murea et al., 2012 Spring) It is necessary to look at alternatives, 
which are not resource-intensive and those which are nearer to the community that 
people live in. (Aswathy et al., 2013)  
 
Yoga holds promise to be a potential therapeutic tool to achieve positive health and 
cure disease. (BK, 2007) Yoga aims at bringing the different bodily functions into 
perfect co-ordination so that they work for the good of the whole body. (Saraswati, 
2009)  Yoga offers a largely unexplored, widely available resource for the 
management of stress-related ailments. (Monra et al., 1992) 
 
Prana (life force) has a very close relation to the mind. As prana of the subtle pranic 
body (pranamaya kosha) is intrinsically linked to the other koshas, annamaya (food 
body), manomaya (mental body), etc., prana is influenced by our thoughts, feelings, 
emotions,etc., and in vice versa they are influenced by prana. (Saraswati, 2002) 
 
Breath, the vital force, is controlled positively by pranayama to ensure homeostasis 
and wellbeing in humans. (Ansari, 2016) The practice of pranayama clears up the 
nadis, energy pathways in the body. However in an average individual, many of these 
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pathways are blocked and the chakras release energy only partially. The negative 
condition (disease/disorder) we experience, whether physical or mental, are the 
causes as well as the consequences of the blockages. With the practice of pranayama, 
these pathways of energy are gradually freed so that prana moves through them 
smoothly. (Saraswati, 2013) 
 
‘Manu’ – the law giver of the Aryans is of the opinion that pranayama clears the body 
and mind as the fire cleans dross elements contained in the gold when heated. Almost 
all the Indian Yogis are of opinion that Asanas free the Sadhaka from Rajoguna; 
Pranayama destroys his bodily and mental abnormalities if any present. This shows 
that Prana and mind are closely related to each other. Mental disturbances like 
excitement, anxiety, fear, anger, disappointment, lust and other mental aberrations can 
be calmed down by regular practice of pranayama which results in several health 
benefits. (Ramdev, 2004) 
 
Pranayama consist of three phases: “puraka” (inhalation), “rechaka” (exhalation), and 
“kumbhaka” (retention); and that can be either fast or slow. Both Bhastrika 
Pranayam and Kapalbhati pranayam belongs to the class of fast breathing technique, 
which when practiced alone were known to have impact on sympathetic activity and 
reduce the stress level, from previous studies. (Sharma et al., 2013) Though, both 
pranayama belongs to the fast type of breathing technique they differ in the way that 
“bhastrika” involves both active inhalation and active exh2eralation whereas 
“kapalbhati” involves passive inhalation and active exhalation. 
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According to the classic text and research papers, Bhastrika (bellows breathe) 
increases vitality and lowers levels of stress and anxiety by raising the energy and 
harmonizing the pranas; Kapalbhati calms the mind, (Saraswati, 2008) tones the 
digestive organs, balances and strengthens the nervous system, (Saraswati, 2013) 
regulates the neuro-endocrine and autonomic nervous system mechanisms in the body. 
(Kekan & Kashalikar, 2013) 
 
Previous study has shown that the practice of yoga (asanas and pranayama) has made 
a significant fall in the fasting blood glucose level and one hour postprandial blood 
glucose level after 40 days of practice, in non-insulin dependent diabetes mellitus 
persons. (Malhotra et al., 2004) In another study, short term intervention of yogic 
exercises (pranyama) helped in reducing the stress in medical students which is 
reflected by improvement in both fasting and post meal glucose level. (Shende et al., 
2013) 
 
Although few studies have shown the practice of pranayama alone improved the blood 
glucose level in healthy volunteers, no such study has been conducted on diabetic 
people. Current study was conducted to evaluate and compare the effect of Bhastrika 
and Kapalbhati Pranayama on blood glucose level in people with Type 2 Diabetes 
Mellitus. 
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2.0 AIM AND OBJECTIVE 
 
2.1 AIM 
The aim is to study the effect of Bhastrika and Kapalbhati Pranayama on 
blood glucose level in type 2 diabetes mellitus. 
 
2.2 OBJECTIVE 
To evaluate and compare the effects of Bhastrika and Kapalbhati pranayama 
on following parameters in type 2 diabetic subjects: 
i. Fasting Blood Sugar (FBS) 
ii. Post-Prandial Blood Sugar (PPBS) 
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3.0 REVIEW OF LITERATURE 
 
3.1 DIABETES MELLITUS 
Diabetes Mellitus is of three main types namely, Type 1 Diabetes Mellitus (an 
autoimmune disease), Type 2 Diabetes Mellitus (due to improper function or 
inadequate secretion of insulin) and Gestational Diabetes (develops during 
pregnancy). The symptoms are almost similar in both type 1 and type 2 
diabetes mellitus, which may develop rapidly (in a weeks or months) in type 1 
diabetes, while it usually develops much slowly or may  be subtle or sometimes 
may be absent in type 2 diabetes mellitus. So, the disease may go undiagnosed 
for several years, until complications arise out of it. 
 
Diabetes is on rise; no longer a disease of predominantly rich nations, rather the 
prevalence is steadily increasing everywhere, most markedly in the world’s low 
and middle-income countries. (World Health Organization, 2016) Type 2 
diabetes is the most common type of diabetes, usually occurs in adults, but is 
increasingly seen in children and adolescents. Although the exact causes for the 
development of type 2 diabetes are still not known, there are several important 
risk factors includes excess body weight, physical inactivity and poor nutrition. 
(International Diabetes Federation, 2015) Severe and sustained emotional 
stress creates a physiological burden through increased sympathetic activity 
and higher energy demand. This, may lead to increased oxidative stress and 
lead to the development of metabolic syndrome. Emotional stress has been 
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shown to contribute to the onset, progression, and control of type 2 diabetes. 
Stress management and biofeedback assisted relaxation have been shown to 
improve glycemic control. (Munster-Segev et al., 2017)  
 
3.1.1 INCIDENCE & PREVALENCE 
The prevalence of diabetes has been steadily increasing for the past three 
decades; mirroring an increase in prevalence of overweight and obesity. The 
number has nearly quadrupled since 1980. (World Health Organization, 
2016) India leads the world with largest number of diabetics, earning the 
dubious distinction of being termed “diabetes capital of the world”. (Mohan et 
al., 2007) India is second to china which is home for more number of diabetics 
in the world. (Gupta et al., 2015) 
 
South Asian people originating from Pakistan, Bangladesh or India, experience 
50% higher risk of developing type 2 diabetes compared with other 
populations, irrespective of whether they live in South-Asia or Western 
countries. (Bhurji et al., 2016) 
 
It has raised from 108 million in 1980 to 422 million people with diabetes in 
the year 2014. The global prevalence of diabetes, among the adults over 18 
years of age has risen from 4.7% in 1980 to 8.5% in 2014. In the year 2015, an 
estimated 1.6 million deaths were directly caused by diabetes. WHO projects 
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that, diabetes will be the 7th leading cause of death by the year 2030. (World 
Health Organization, 2017) 
 
In South East Asia region, it was estimated that about 78.3 million people aged 
between 20-79 years were affected with diabetes in the year 2015 and the 
number is projected to raise 140.2 million by the year 2040. (International 
Diabetes Federation, 2015)  
 
Table 3.1 – Global scenario of diabetes 
 (International Diabetes Federation, 2015) 
 
DIABETES 
 
In 2015 
 
By 2040 
 
Prevalence 
 
One in 11 adults has diabetes 
 
One in 10 adults will have diabetes 
 
Men 
 
215.2 million 
 
328.4 million 
 
Women 
 
199.5 million 
 
313.3 million 
 
Urban area 
 
269.7 million 
 
477.9 million 
 
Rural area 
 
145.1 million 
 
163.9 million 
 
11 
 
Preliminary results from a large community study conducted by the Indian 
Council of Medical Research (ICMR) revealed that, lower proportion of the 
population is affected in the states of Northern India [Chandigarh – 0.12 
million, Jharkhand – 0.96 million] as compared to Maharashtra [9.2 million] 
and Tamil Nadu [4.8 million]. The national urban survey conducted across 
metropolitan cities of India also reported similar trend which is as follows: 
Eastern India [Kolkata – 11.7%], Northern India [Kashmir Valley – 6.1%, New 
Delhi – 11.6%], West India [Mumbai – 9.3%], South India [Chennai – 13.5%, 
Hyderabad – 16.6%, Bangalore – 12.4%]. (Kaveeshwar & Cornwall, 2014) 
 
Genetic predisposition combined with lifestyle associated with urbanization 
and globalization contributes to the rapid rise of diabetes burden in India. 
Moreover type 2 diabetes mellitus appears to occur at least a decade earlier in 
Indian than in European population. According to American Diabetes 
Association criteria, the prevalence of diabetes was 4.7% in urban and 1.9% in 
rural areas whereas the prevalence according to World Health Organization 
criteria was 5.9% in urban and 2.7% in rural areas. The economic burden due 
to diabetes in India is among the highest in the world. However, the real burden 
of diabetes is due to its micro-vascular and macro-vascular complication, 
which leads to increased mortality and morbidity. (Joshi, 2015) 
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3.1.2 CHARACTERISTIC FEATURES OF TYPE 2 DIABETES MELLITUS 
Table 3.2 – Characteristic features of type 2 diabetes mellitus, (Campbell, 2000) 
 Onset usually occurs in patients >30 years of age 
 Onset is often insidious 
 Positive family history in 30% of cases 
 No association with HLA; no islet cell antibodies (as in type 1 diabetes 
mellitus) 
 Symptoms were controlled by the diet and/ or oral hypoglycemic agents, 
insulin treatments may be required later in the disease if uncontrolled. 
 
 
3.1.3 CLINICAL PRESENTATION OF TYPE 2 DIABETES MELLITUS 
Type 2 Diabetes may present to the clinician in one of the four ways, (i) 
classical symptoms (may be seen at diagnosis) are thirst, polyuria, fatigue and 
malaise, infections (especially genital candidiasis) and blurred vision (ii) 
Incidental diagnosis include opportunistic urine and blood testing for glucose 
done in older individuals at the time of illness, either at the primary or 
secondary care level, or as a part of an annual health check (iii) Complications 
of diabetes viz. micro- and macro-vascular disorder (iv) Hyperosmolar 
Nonketotic Coma (HONK) is a form of diabetic coma seen in older type 2 
diabetic patients often seen at diagnosis in previously undiagnosed subjects. 
(Campbell, 2000) 
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3.1.4 DIAGNOSTIC CRITERIA 
Table 3.3 – Criteria for the diagnosis of diabetes 
 (American Diabetes Association, 2017) 
 
Fasting Plasma Glucose (FPG) ≥ 126 mg/dL (7.0 mmol/L). Fasting is defined 
as no caloric intake for at least 8 hr.* 
OR 
2-hour Plasma Glucose (2-h PG) ≥ 200 mg/dL (11.1 mmol/L) during an Oral 
Glucose Tolerance Test (OGTT). The test should be performed as described by 
the WHO, using a glucose load containing the equivalent of 75g anhydrous 
glucose dissolved in water.* 
OR 
HbA1C ≥ 6.5% (48 mmol/mol). The test should be performed in a laboratory 
using a method that is NGSP1 certified and standardized to the DCCT2 assay.* 
OR 
In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a 
random plasma glucose ≥ 200 mg/dL (11.1 mmol/L). 
 
*In the absence of unequivocal hyperglycemia, results should be confirmed by repeat 
testing. 
 
1 – National Glycohemoglobin Standardization Program 
2 – Diabetes Control and Complications Trial 
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Table 3.4 – Oral Glucose Tolerance Test (OGTT) 
 (Frier & Fisher, 2010) 
 
 
How to perform an Oral Glucose Tolerance Test (OGTT) 
Preparation before the test 
 Unrestricted carbohydrate diet for 3 days 
 Fasted overnight for at least 8 hrs 
 Rest for 30 mins 
 Remain seated for the duration of the test, with no smoking 
Sampling 
 Plasma glucose is measured before and 2hrs after a 75 g oral glucose drink 
Interpretation (venous plasma glucose) 
 
Fasting hyperglycemia 
 
 
Impaired glucose 
tolerance 
 
Diabetes 
Fasting 
6.1-6.9 mmol/L 
(110-125 mg/dL) 
 
< 7.0 mmol/L 
(< 126 mg/dL) 
 
≥ 7.0 mmol/L 
(≥ 126 mg/dL) 
2hrs after glucose load 
< 7.8 mmol/L 
(< 140 mg/dL) 
 
7.8-11.0 mmol/L 
(140-199 mg/dL) 
 
≥ 11.1 mmol/L 
(≥ 200 mg/dL) 
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Indication for diabetes screening in asymptomatic individuals includes the following 
criteria: (Khardori, 2017) 
 Sustained blood pressure of >135/80 mmHg 
 Overweight and one or more other risk factors for diabetes (e.g., blood 
pressure > 140/90 mmHg, HDL level < 35 mg/dL, triglyceride level > 
250 mg/dL) 
 ADA recommends screening at age of 45 years in the absence of the 
above criteria. 
3.1.5 RISK FACTORS 
Though researchers fully don’t understand why some people develop type 2 
diabetes and others do not, however it is clear that certain factors increases the 
risk of developing type 2 diabetes which includes weight, fat distribution, 
physical inactivity, family history, race, age, pre-diabetes, gestational diabetes 
and polycystic ovarian syndrome. (Mayo Clinic, 2016) 
i. Weight – Overweight being the primary risk factor to develop 
diabetes, though people need not to be overweight to develop 
diabetes. If more fatty tissue present in a body, more resistant the 
cells become to insulin. 
ii. Fat distribution – If there is more fat deposition in or around the 
abdomen, greater is the risk to develop type 2 diabetes compared 
with that of fat deposition elsewhere (hips/thighs) in the body. 
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iii. Inactivity – Physical activity helps to control weight by using 
glucose as energy and makes cells more sensitive to insulin. Physical 
inactivity or less activity increases the risk of type 2 diabetes. 
iv. Family history – Greater is the risk to develop diabetes, if 
parents/siblings has type 2 diabetes. 
v. Race – Although it is not clear why certain race have greater 
incidence, certain races like blacks, Hispanics, American Indians and 
Asian Americans are more likely to develop type 2 diabetes 
compared with that of whites. 
vi. Age – Older the individual more risk is to develop type 2 diabetes 
due to less exercise, lose muscle mass and weight gain, especially 
after the age of 45. But more recently, there is dramatic increase in 
the incidence of type 2 diabetes even among children, adolescent and 
younger adults. 
vii. Prediabetes – Is a condition in which blood sugar level is higher 
than normal, but not high enough to be classified as diabetes, often 
may progresses to type 2 diabetes. 
viii. Gestational diabetes – If a woman gets diabetes during pregnancy 
or is she gives birth to baby weighing more than 9 pounds (4 
Kilogram), risk of developing type 2 diabetes increases. 
ix. Polycystic ovarian syndrome – Women having PCOS – a condition 
characterized by irregular menstrual cycle, excess bodily hair growth 
and obesity, increases the risk of diabetes. 
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3.1.6 COMPLICATIONS 
Table 3.5 - Complications of diabetes mellitus 
 (Graham Douglas, 2011) 
 Micro vascular / neuropathic complications 
Retinopathy – cataract, impaired vision 
Nephropathy – protein loss, renal failure 
Peripheral neuropathy – sensory loss, motor weakness 
Autonomic neuropathy – postural hypotension, vomiting, diarrhea 
Foot disease – ulceration, arthropathy 
Macro vascular complications 
Coronary circulation – Myocardial ischaemia/infarction 
Cerebral circulation – Transient ischaemic attack (TIA), stroke 
Peripheral circulation – Claudication, gangrene, amputation 
 
Other possible complication includes the following: (Mayo Clinic, 2016) 
 Hearing impairment – Hearing problems are more common in people 
with diabetes 
 Skin Conditions – Diabetes makes more susceptible to skin problems, 
includes bacterial & fungal infections. 
 Alzheimer’s disease – Type 2 DM may increase the risk of Alzheimer’s. 
Poorer the blood control greater is the risk, but the exact connection 
between the 2 still remains unclear 
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3.1.7 PATHOPHYSIOLOGY (STRESS MECHANISM) 
Type 2 diabetes mellitus is characterized by combination of peripheral insulin 
resistance and inadequate secretion of insulin by the pancreatic beta cells. 
Insulin resistance which has been attributed to elevated levels of free fatty acids 
& pro-inflammatory cytokines in the plasma, that leads to decreased glucose 
transport into the muscle cells, elevated hepatic glucose production and 
increased breakdown of fat from body tissue. (Khardori, 2017) 
Pathophysiology of Type 2 diabetes mellitus and its co-morbidities has been 
correlated with stress mechanism. Stress suppresses body’s immune system and 
neuro-humoral actions thereby affecting the normal psychological state. (Singh 
et al., 2015)  
 
The hyperglycemic effects of the stress were noted as early as in the 17th 
century by Thomas Willis; His work was followed in 1849 by Claude Bernard, 
who demonstrated that “causing lesion in an area of hypothalamus in normal 
rabbits causes hyperglycemia”, giving a early credence to theories that 
hypothalamic pituitary axis plays a distinct role in the development of 
hyperglycemia. In 1930, C.F. Cori, who chose ‘pharmacological stress 
response mechanism’ for his experiment with rabbits and theorized the link 
between the physiological stress response and development of hyperglycemia. 
Later Cannon examined the ‘response to a physiological stress’ in cats and 
found that the glycosuria was absent at baseline, but developed in animals that 
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were observed to respond to restraint with emotions of fright or rage. (Surwit, 
2008) 
 
The potential role of stress in type 2 diabetes mellitus was noted a century ago 
by William Osler and recommended stress-reducing maneuvers for the 
treatment for this form of disease. More recently a theoretical rationale for the 
importance of stress effects, on glycemic control in type 2 diabetes mellitus has 
emerged from the animal studies. These uniformly suggest that stress can affect 
glycemic control adversely in type 2 diabetes mellitus. Evidence from both 
animal and human studies suggests that individuals with type 2 diabetes have 
altered adrenergic sensitivity in the pancreas, and perhaps other site as well, 
which could make the individual particularly sensitive to stressful 
environmental stimuli; other stimuli of sympathetic activity such as dietary fat 
and simple carbohydrates also may contribute more to the development of 
diabetes mellitus through this adrenergic mechanism. (Surwit et al., 1992) 
 
3.1.7.1 How does stress increase blood glucose? 
Whenever there is a stress, the glucose needs to go up. This rise is essential to 
supply the extra energy that is necessary for the highly increased muscle work 
to run away from the sensed danger. The endocrine and autonomic nervous 
system that regulate all the stress adaptation mechanism are also involved in 
the regulation of the blood glucose level. In addition to this, there is a separate 
direct regulation of the blood glucose regulating hormonal system that is active 
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not only during stress but it monitors and regulates a constant level of glucose 
in the blood all the time. The hormone that increases the blood glucose level is 
“glucagon” and that which reduces is “insulin”. Whenever there is a threat or 
danger, the sympathetic nerves system activates and release large qualities of 
stress chemicals called adrenalin and nor-adrenalin. Stress also releases other 
hormones such as cortisol (steroids), thyroid hormones, and growth hormones 
in to the blood. All these chemicals actively increases the blood glucose levels 
and thus during stress the blood glucose may shoot up much beyond the levels 
necessary. Although, this process of excessive release of blood glucose during 
emotional stress is common to both diabetics and non-diabetics, it remains high 
in diabetics because necessary amount of the insulin from the target beta cells 
is not released instantaneously to transport all excess glucose into the cells. 
Because of the inability (insufficiency or inefficiency) of the cell to manage to 
supply this sudden demand, the blood glucose remains high for a long time 
even after a short duration of emotional upsurge. Although, the external 
situations are not posing demand, on the emotional state of the individual the 
internal restlessness, unquenchable ambitions, unnecessary anxieties and 
apprehensions of unfounded fears, could be the major demands that can keep 
the blood sugar at very high levels. Repeated long standing emotionally 
demanding situations with large quantities of stress tend to increase blood 
glucose level even if we are more conscious with food and exercise. Although 
it is unclear whether psychosocial stress exerts a direct psychosomatic effect on 
the neuro-endocrine regulatory mechanisms that influence metabolic control, it 
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is quite clear that stress can influence a person’s compliance behavior in ways 
that lead to difficulties in metabolic control. (Srikanta et al., 2010) 
 
The pancreatic beta cell failure was categorized as follows. (i) Reduced Beta 
Cell Numbers – beta cell death resulting in reduced beta cell mass that cannot 
deliver sufficient insulin or alternatively it is possible, if the individual with a 
lower potential for beta cell regeneration fail to increase beta cell mass when 
demand is higher, opening a gap between demand and supply, which 
eventually causes hyperglycemia.  (ii) Beta Cell Dysfunction – it has been 
proposed that metabolic load may lead to severe endoplasmic reticulum (ER) 
stress in beta cells, and that cellular adaptation to ER stress namely the 
unfolded protein response (UPR), can reduce the glucose stimulated insulin 
secretion. Otherwise chronic oxidative stress resulting from improper glucose 
metabolism may cause pancreatic beta cell dysfunction. (iii) Loss of Beta Cell 
Identity – as a capable cell for synthesizing, processing and secreting mature 
insulin in response to metabolic, hormonal and neurologic stimuli or at the 
molecular level cell that express the full complement of genes associated with 
secretion of regulated normal insulin, if it loses its identity may eventually lead 
to type 2 diabetes. (Swisa et al., 2017) 
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3.1.7.2 Regulation of Glucose Homeostasis 
3.1.7.2 (a) Overall regulation of glucose homeostasis 
Glucose homeostasis reflects a balance between hepatic glucose production and 
peripheral glucose uptake and utilization. Insulin is the most important 
regulator of this metabolic equilibrium, but neural input, metabolic signals, and 
other hormones (e.g., glucagon) result in integrated control of glucose supply 
and utilization. The organs that regulate glucose and lipids communicate by 
neural and humoral mechanisms with fat and muscle producing adipokines, 
myokines, and metabolites that influence liver function. In the fasting state, low 
insulin levels increase glucose production by promoting hepatic 
gluconeogenesis and glycogenolysis and reduce glucose uptake in insulin-
sensitive tissues (skeletal muscle and fat), thereby promoting mobilization of 
stored precursors such as amino acids and free fatty acids (lipolysis). Glucagon, 
secreted by pancreatic alpha cells when blood glucose or insulin levels are low, 
stimulates glycogenolysis and gluconeogenesis by the liver and renal medulla. 
Postprandially, the glucose load elicits a rise in insulin and fall in glucagon, 
leading to a reversal of these processes. Insulin, an anabolic hormone, 
promotes the storage of carbohydrate and fat and protein synthesis. The major 
portion of postprandial glucose is used by skeletal muscle, an effect of insulin-
stimulated glucose uptake. Other tissues, most notably the brain, use glucose in 
an insulin-independent fashion. Factors secreted by skeletal myocytes (irisin), 
adipocytes (leptin, resistin, adiponectin, etc.), and bone also influence glucose 
homeostasis. (Powers, 2015) 
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3.1.7.2 (b) Insulin Biosynthesis 
Insulin is produced in the beta cells of the pancreatic islets. It is initially 
synthesized as a single-chain 86-amino-acid precursor polypeptide, 
preproinsulin. Subsequent proteolytic processing removes the amino-terminal 
signal peptide, giving rise to proinsulin. Proinsulin is structurally related to 
insulin-like growth factors I and II, which bind weakly to the insulin receptor. 
Cleavage of an internal 31-residue fragment from proinsulin generates the C 
peptide and the A (21 amino acids) and B (30 amino acids) chains of insulin, 
which are connected by disulfide bonds. The mature insulin molecule and C 
peptide are stored together and co-secreted from secretory granules in the beta 
cells. Because C peptide is cleared more slowly than insulin, it is a useful 
marker of insulin secretion and allows discrimination of endogenous and 
exogenous sources of insulin in the evaluation of hypoglycemia. Pancreatic 
beta cells co-secrete islet amyloid polypeptide (IAPP) or amylin, a 37-amino-
acid peptide, along with insulin. The role of IAPP in normal physiology is 
incompletely defined, but it is the major component of the amyloid fibrils 
found in the islets of patients with type 2 diabetes, and an analogue is 
sometimes used in treating type 1 and type 2 DM. Human insulin is produced 
by recombinant DNA technology; structural alterations at one or more amino 
acid residues modify its physical and pharmacologic characteristics (Powers, 
2015) 
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3.1.7.2 (c) Insulin Secretion 
Glucose is the key regulator of insulin secretion by the pancreatic beta cell, 
although amino acids, ketones, various nutrients, gastrointestinal peptides, and 
neurotransmitters also influence insulin secretion. Glucose levels >3.9 mmol/L 
(70 mg/dL) stimulate insulin synthesis, primarily by enhancing protein 
translation and processing. Glucose stimulation of insulin secretion begins with 
its transport into the beta cell by a facilitative glucose transporter. Glucose 
phosphorylation by glucokinase is the rate-limiting step that controls glucose-
regulated insulin secretion. Further metabolism of glucose-6-phosphate via 
glycolysis generates ATP, which inhibits the activity of an ATP-sensitive K+ 
channel. This channel consists of two separate proteins: one is the binding site 
for certain oral hypoglycemic (e.g., sulfonylureas, meglitinides); the other is an 
inwardly rectifying K+ channel protein (Kir6.2). Inhibition of this K+ channel 
induces beta cell membrane depolarization, which opens voltage-dependent 
calcium channels (leading to an influx of calcium) and stimulates insulin 
secretion. Insulin secretory profiles reveal a pulsatile pattern of hormone 
release, with small secretory bursts occurring about every 10 min, 
superimposed upon greater amplitude oscillations of about 80–150 min. 
Incretins are released from neuroendocrine cells of the gastrointestinal tract 
following food ingestion and amplify glucose-stimulated insulin secretion and 
suppress glucagon secretion. Glucagon-like peptide 1 (GLP-1), the most potent 
incretin, is released from L cells in the small intestine and stimulates insulin 
secretion only when the blood glucose is above the fasting level. Incretin 
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analogues or pharmacologic agents that prolong the activity of endogenous 
GLP-1 enhance insulin secretion. (Powers, 2015) 
 
3.1.7.2 (d) Insulin Action 
Once insulin is secreted into the portal venous system, ~50% is removed and 
degraded by the liver. Un-extracted insulin enters the systemic circulation 
where it binds to receptors in target sites. Insulin binding to its receptor 
stimulates intrinsic tyrosine kinase activity, leading to receptor 
autophosphorylation and the recruitment of intracellular signaling molecules, 
such as insulin receptor substrates (IRS). IRS and other adaptor proteins initiate 
a complex cascade of phosphorylation and dephosphorylation reactions, 
resulting in the widespread metabolic and mitogenic effects of insulin. As an 
example, activation of the phosphatidylinositol-3′-kinase (PI-3-kinase) pathway 
stimulates translocation of a facilitative glucose transporter (e.g., GLUT4) to 
the cell surface, an event that is crucial for glucose uptake by skeletal muscle 
and fat. Activation of other insulin receptor signaling pathways induces 
glycogen synthesis, protein synthesis, lipogenesis, and regulation of various 
genes in insulin-responsive cells. (Powers, 2015) 
 
3.1.7.3 How Insulin Resistance develops? 
Insulin resistance, a complicated condition in which three primary metabolic 
tissues viz. skeletal muscle, liver and white adipose tissue sensitive to insulin 
become less sensitive and its downstream metabolic actions under normal 
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serum glucose concentration. Inflammation plays an important role in the 
development of insulin resistance via various cytokines and molecular 
pathways. (Chen et al., 2015) 
 
While genetics, aging and ethnicity plays a major role in developing insulin 
sensitivity, the driving force behind the development of insulin resistance 
include, excess body weight, increased fat deposition in abdomen, lack of 
exercise, smoking and skimping on sleep. As insulin resistance develops, the 
body tries to fight back by producing more amount of insulin. Over the months 
and years, β-cells of pancreas that works so hard to make insulin gets worn out 
and can no longer keep pace with the demand for insulin requirement. After 
years of insulin resistance, blood sugar may begin to rise which may 
consequently lead to development of prediabetes or type 2 diabetes. (Harrar, 
2016) 
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Table 3.6 - Illustrate some causes of Insulin Resistance 
 (Guyton & Hall, 2006) 
 
Some causes of Insulin Resistance 
 
 Obesity/overweight (especially excess visceral adiposity) 
 Excess glucocorticoids (Cushing’s syndrome or steroid therapy) 
 Excess growth hormone (acromegaly) 
 Pregnancy, gestational diabetes 
 Polycystic ovary disease 
 Lipodystrophy (acquired or genetic; associated with lipid accumulation in liver) 
 Autoantibodies to the insulin receptors 
 Mutations of insulin receptors 
 Mutations of the peroxisome proliferators’ activator receptor γ (PPARγ) 
 Mutation that cause genetic obesity (e.g., melanocortin receptor mutations) 
 Hemochromatosis (a hereditary disease that causes tissue iron accumulation) 
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3.1.7.4 Type 2 Diabetes Mellitus: Direct and Indirect impact of stress 
At present, the causes of Type 2 Diabetes are not entirely clear, but predictors 
have been found in recent studies namely, obesity, hypertension, and sedentary 
lifestyle, alterations in the glycemic status and lipid metabolism correlate with 
Type 2 Diabetes and its diffusion. Insulin resistance and other conditions with 
degrees of glucose intolerance commonly occur together with a collection of 
clinical and biochemical features, known as “Metabolic Syndrome” (MS). The 
term defines a cluster of components that reflect over-nutrition, sedentary 
lifestyles and an excess of adiposity. Metabolic Syndrome is usually a pre-
clinical condition; genetic predisposition and lifestyle (overweight, sedentary 
lifestyle, bad dietary habits) lead individuals to develop Type 2 Diabetes 
Mellitus. The physiological changes triggered by stress may directly affect the 
endocrine and immune system. On other hand, the reaction to the stressor (in 
some cases) may consist, developing an unhealthy lifestyle, neglect of physical 
well-being, eating in a disorderly fashion, often using food in a consoling or 
compensatory manner may indirectly affect the risk of developing the disease - 
Type 2 Diabetes Mellitus. (Falco et al., 2015) 
 
3.1.7.4 (i) Stress – Cortisol – Diabetes 
Cortisol is one of the prime actors mediating the effect of stress on metabolism 
in general and on glucose metabolism in specific. It increases the blood glucose 
levels by stimulating hepatic gluconeogenesis and inhibiting the action of 
insulin. This reaction is entirely useful in case of fight and flight reaction but 
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are not entirely suited to cope with the stressors triggered by modern life, 
which are mostly relational, intangible and durable that may induce chronic 
hypercortisolism, likely to facilitate the onset of metabolic syndrome and Type 
2 Diabetes Mellitus. (Falco et al., 2015) 
 
3.1.7.4 (ii) Disease itself as a source of stress 
Getting ill may cause personal and interpersonal conflicts, where normal 
rhythms of the life are disrupted, forcing an individual to question personal 
values and long-term objectives. Type 2 Diabetes require a complex and 
largely self-managed treatment which includes daily use of drugs 
(insulin/hypoglycemic agents), regular measurement of blood glucose levels, 
special attention to diet and everyday activities. The requirement of shift from 
the established routines may create emotional and cognitive fatigue. The need 
to control aspects of life which were once considered to be very normal can be 
experienced as loss of freedom and spontaneity. Some people may develop an 
image that their body is different from the past and compared to that of the 
peers, this diversity might be interpreted in a negative way. On behavior aspect, 
one can observe different reactions, depending not only on severity of clinical 
situation, but also based on his/her personality, self-esteem and social support. 
Hence, the early identification and treatment of these issues may help to 
develop an adaptive style of coping, which will bring about positive result on 
compliance and metabolic balance. In addition, it may help to prevent the risk 
of long term complications. (Falco et al., 2015) 
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3.1.7.4 (iii) Impact of stress on diabetes progression 
It is difficult to define or measure the role of stress in the etiology of diabetes, 
but there is significant evidence suggest of stress’s’ metabolic consequences in 
an individual who already suffering from chronic disease like diabetes mellitus. 
Psychological strain activates the neuro-endocrine mechanism, which influence 
the blood glucose level through the release of cortisol, endorphins and growth 
hormones. This mechanism has an adaptive importance in a healthy individual 
whereas the chronic stress-induced hyperglycemia may aggravate the disease. 
These mechanisms usually affects the young people, for whom the endocrine 
system continuously undergoes adaptation making them particularly sensitive 
to the effects of environmental stimuli whereas in case of the elderly people, 
stress plays a major role in the development of complications such as 
neuropathy, nephropathy and retinopathy. Along with this, if a person presents 
with negative emotions, may reduce and undermine the willingness to comply 
with the treatments and diets; thus a vicious cycle of poor compliance, poor 
glycemic control, nervousness and physical vulnerability is established. This, in 
turn makes the people more difficult to adapt to cope with any new problem 
that arises. Therefore, care must be given to the people suffers with diabetes, 
through the process which supports resilience and improving the self-efficacy 
of the person, favoring the activation of problem-focused coping in them. 
Treatment plans should also involve the families so they can help their family 
member to adapt to the illness. Some research in the developmental psychology 
has shown that ‘there is a connection between parents’ stress and that of their 
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diabetic children’ which may influence the quality of glycemic control. Hence, 
family support is also an important factor in adult diabetic patient. Partner’s 
attitude influences the adherence to the treatment and the psychological impact 
on the disease has been shown to be more serious in type 2 diabetics who live 
alone compared to type 2 diabetics who were with their family support. (Falco 
et al., 2015) 
 
3.1.8 CONVENTIONAL MANAGEMENT 
The goals of the therapy for type 2 diabetes mellitus are to (i) eliminate the 
symptoms related to hyperglycemia, (ii) reduce or eliminate the long-term 
microvascular and macrovascular complications of diabetes and (iii) allow the 
patient to achieve as normal a lifestyle as possible. To reach these goals, the 
physicians should identify target level of glycemic control for each patient; 
provide the patient with educational and pharmacological resources necessary 
to reach this level, and monitor/treat diabetes related complications. (Powers, 
2015) 
 
3.1.8.1 PHARMACOTHERAPY 
The main classes of the drugs used in the management of type 2 diabetes are 
heterogeneous in their modes of action, safety profiles and tolerability which 
include agents that stimulate insulin secretion (sulphonylureas and rapid-acting 
secretagogues), reduce hepatic glucose production (biguanides), delay 
digestion and absorption of intestinal carbohydrate (alpha-glucosidase 
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inhibitors) or improve insulin action (thiazolidinediones). (Krentz & Bailey, 
2005) The new drug classes have indeed come in the market such as SGLT-2 
inhibitors and others are in the experimental stages such as GPR 40 agonists, 
GSK-3 inhibitors, GK activators and GPR21 inhibitors which definitely could 
be anticipated as safe and effective, for diabetes therapy. (Kumar et al., 2017) 
 
3.1.8.2 SURGICAL INTERVENTION 
Bariatric surgery is emerging as a powerful weapon against obesity and type 
2 diabetes. There is accumulating evidence that surgery with gastrointestinal 
manipulations has a role in metabolic regulation and may result in remission 
of type 2 diabetes (metabolic surgery). The major mechanisms mediating the 
weight loss-independent effects of bariatric surgery comprise, its effects on 
tissue-specific insulin sensitivity, β-cell function & incretin responses, change 
in bile acid composition & flow, modification of gut flora, intestinal glucose 
metabolism and increased brown adipose tissue metabolic activity. According 
to recently released guidelines, bariatric surgery should be recommended in 
diabetic patient who satisfies one or more of the following criteria: (i) class III 
obesity, regardless of their level of glycemic control; (ii) class II obesity with 
inadequately controlled type 2 diabetes despite change in lifestyle and optimal 
medical therapy; (iii) class I obesity and inadequately controlled 
hyperglycemia, despite optimal medical treatment. (Koliaki et al., 2017) 
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3.1.9 YOGA AND TYPE 2 DIABETES MELLITUS 
The concept of disease is found in the treatise called “Yogavāsiṣṭha”.  
According to Yogavāsiṣṭha, the modern diseases such as asthma, diabetes, 
hypertension, and anxiety are called “Ādhija Vyādhi” (stress born diseases). 
These stress born diseases originating in Manomaya Kośa – the astral layer of 
our existence. They arise from our actions that are governed by our emotions 
[strong likes and dislikes] rather than what is right or wrong. Often in this 
phase, we respond to emotions – the pull of senses knowing completely well 
that we are going against what is right. This is called Prajnāparādha  in 
Āyurveda – mistake at the level of inner consciousness. It is this ‘going 
against what is right’ (the cosmic law) that causes imbalance – a disease at the 
Manomaya Kośa called Ādhi. If it is not approached properly, this will bring 
imbalances at the level of Prāṇamaya Kośa that shows up as breathing jerks, 
imbalances and speed. This in turn creates stress reactions causing autonomic 
and endocrine imbalances leading to diseases in the body called “Vyādhi”. 
Yoga practices help in bringing about the balance at all the level of existence 
(five Kośas) thereby, complete health can be restored. (Srikanta et al., 2010) 
Yoga is a mind-body technique being holistic in nature; it is the best means for 
achieving physical, mental, social and spiritual well being in an individual. 
(Madanmohan, n.d.) To advocate yoga as a cost-effective primary treatment 
especially for people with mild-moderate type 2 diabetes, counseling at 
individual/family level and awareness at community level need to be planned. 
(More & Jagannathan, 2015) 
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3.1.10 MECHANISM OF ACTION OF YOGA IN DIABETES MELLITUS 
A proposed model of mechanism of yoga in people with diabetes mellitus 
involves two interactive pathways, (i) by reducing the activation and 
reactivation of the sympathoadrenal system and the hypothalamic pituitary 
adrenal axis and promoting feelings of well-being. Yoga may alleviate the 
effects of stress and encourage multiple positive downstream effects on 
metabolic function, neuro-endocrine status and related systemic inflammatory 
responses (ii) by directly stimulating the vagus nerve, yoga may enhance 
parasympathetic activity and lead to positive changes in cardiovagal function, 
in mood and energy state, in related neuro-endocrine, metabolic and 
inflammatory responses. In many research studies, yogic intervention has been 
show to positively influence several risk factors of diabetes mellitus such as 
stress, insulin resistance, obesity and sedentary life style. (Cramer et al., 
2015) Pranayama breathing exercises appear to alter autonomic responses to 
breath holding probably by increasing the vagal tone and decreasing 
sympathetic discharges. (Bhargava et al., 1988) 
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3.2  RESEARCH ARTICLE - REVIEW 
3.2.1 PSYCHOSOCIAL STRESS AND TYPE 2 DM 
Stress has long been suspected as having major effects on metabolic activity. 
The effect of stress on glucose metabolism are mediated by a variety of 
“counter-regulatory” hormones that are released in response to stress and that 
result in elevated blood glucose levels and decreased insulin action. This 
energy mobilizing effect is of adaptive importance in a healthy organism. 
However, in diabetes, because of a relative or absolute lack of insulin, stress-
induced increases in blood glucose cannot be adequately metabolized. Thus, 
stress is a potential contributor to chronic hyperglycemia in diabetes, although 
its exact role is unclear. They concluded that further research is needed to 
establish the importance of behavioral factors in the etiology and management 
of diabetes, and several areas of methodological improvement are suggested. 
(Surwit & Schneider, 1993) 
 
Many patients believe that their diabetes has been caused by stress or an 
adverse life event. Whereas there is strong evidence that psychological stress is 
related to a deterioration in glycemic control in established diabetes, there is 
much less evidence that psychological stress can cause diabetes in humans de 
novo. (Wales, 1995) 
 
Herpertz et al., 2000 found that a considerable number of diabetic patients 
suffer from extreme psychosocial stress often associated with poor diabetic 
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control. They concluded that, these patients need psychosocial care which 
should primarily be offered in diabetologic centers incorporating both the 
patients’ family and family background. (Herpertz et al., 2000) 
 
3.2.2 OXIDATIVE STRESS AND TYPE 2 DM 
Oxidative stress – a deleterious factor which is observed to be increased in 
metabolic syndrome, leading to dyslipidaemia, β-cell dysfunction. Impaired β-
cell functioning results in an under production of insulin, impairs glucose 
stimulated insulin secretion, fasting hyperglycemia and eventually the 
development of Type 2 Diabetes Mellitus. (Tangvarasittichai, 2015)  
 
Oxidative stress is produced under diabetic conditions and is likely involved in 
progression of pancreatic beta-cell dysfunction. Possibly caused by low levels 
of antioxidant enzyme expression, pancreatic beta-cells are vulnerable to 
oxidative stress. When beta-cell-derived HIT-T15 cells or isolated rat islets 
were exposed to oxidative stress, insulin gene expression was markedly 
decreased. In their study, they evaluated the effects of antioxidants in diabetic 
C57BL/KsJ-db/db mice. From their observation they concluded that, oxidative 
stress and consequent activation of the JNK pathway (Jun amino-terminal 
kinases/c-Jun N-terminal Kinase are members of the MAPK-Mitogen Activated 
Protein Kinase family and are activated by a variety of environmental stresses, 
inflammatory cytokines, growth factors and GPCR-G Protein-Coupled 
Receptors agonists)  are involved in progression of beta-cell dysfunction found 
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in diabetes. Antioxidants may serve as a novel mechanism-based therapy for 
type 2 diabetes. (Kajimoto & Kaneto, 2004) 
 
Robertson et al., 2007 made a hypothesis that residual hyperglycemia, 
especially after meals generates reactive oxygen species (ROS), which in turn 
causes chronic oxidative stress on the beta cell. The molecular mechanism 
responsible for the glucose toxic effect on beta cell function involves 
disappearance of two important regulators of insulin promoter activity, PDX-1 
(also known as insulin promoter factor 1) and MafA. Antioxidant treatment in 
vitro prevents disappearance of these two transcription factors and normalizes 
insulin gene expression. These observations suggest that the ancillary treatment 
with antioxidants may improve outcomes of standard therapy of type 2 diabetes 
in humans. (Robertson et al., 2007) 
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3.2.3 COMPLEMENTARY & ALTERNATIVE MEDICINE AND TYPE 2 DM 
Complementary and Alternative Medicine (CAM) is a rapidly evolving field of 
medicine that consists of therapy used as an adjuvant or alternative to the 
conventional medicines/therapy. The National Center for Complementary and 
Alternative Medicine (NCCAM) defines CAM as ‘a group of diverse medical 
and health care systems, practices and products that are not presently 
considered to be part of conventional medicine’. CAM therapies are broadly 
classified by the NCCAM into: (i) biologically based therapies (e.g. herbs, 
dietary supplements, aromatherapy, oxygen therapy), (ii) mind-body 
interventions (e.g. yoga, hypnotherapy), (iii) energy therapies (e.g. Reiki, Tai 
Chi), (iv) manipulative and body based methods (e.g. chiropractic, 
reflexology), and (v) alternative medical systems (e.g. homeopathy, Chinese 
herbal medicine, naturopathy). The CAM include major therapeutic lifestyle 
changes which are accessible, effective and cost-effective when used alone or 
as an adjuvant, which offer improvements in physical health, self-esteem and 
quality of life. (Suri et al., 2016) 
 
Lee et al., 2004 made a survey to measure the prevalence of complementary 
and alternative medicine (CAM) use among Korean diabetes mellitus patients. 
Out of 223 respondents, 65% had taken CAM products, while 35% of them had 
not taken the CAM products. A total of 57.9% of the users felt that it was 
effective, 30.3% of the user considered that it regulated their blood glucose 
level and 27.6% users felt that it was effective in achieving psychological 
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relaxation. Out of ninety three CAM materials used by the respondents, 63.7% 
were plant based materials, 21.6% were animal materials and 14.7% were the 
mixture of both. The majority of the diabetes patients (81.2%) were trying new 
type of CAM materials and one-third of all patients were trying to start using 
new CAM products after consulting with their physicians. They concluded that 
doctors should recognize that CAM were widely used by the diabetic patients 
and should appreciate that these medicine can even cause adverse effects, so 
they should therefore be prepared to question patients to determine what non-
conventional medicines they are using and rule out what possible outcome that 
may bring about in their patients. (Lee et al., 2004)  
 
Ogbera et al., 2010 in their study found that CAM usage is an important facet 
of management of diabetes mellitus among their patients, with biological based 
therapies being the most prevalent form of CAM being utilized. Despite 
complementary & alternative medicine usage, adherence to prescribed 
medications was high and they concluded that further evaluation of the impact 
of CAM on hyperglycemia is needed. (Ogbera et al., 2010) 
 
Manya et al., 2012 concluded that respondents with diabetes, who participated 
in the study, frequently use CAM to treat their diabetes and for their general 
health. Health care professionals should be aware of CAM use by people with 
diabetes and take a through history to document any such usage by their 
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patients so as to monitor outcomes which might either be a beneficial or 
potential side effects produced by CAM usage. (Manya et al., 2012) 
 
3.2.4 WATER DRINKING AND TYPE 2 DM  
Naumann et al., 2017 made a meta-analysis of prospective cohort studies, 
other observational studies, studies with animal models and interventional 
studies using hydrogencarbonated and magnesium supplements, suggest a 
probable positive effect of drinking water and mineral water in particular on 
glycemic parameters. Supporting positive results were found in some of 
randomized controlled studies, especially those substituting diet 
beverages/caloric beverages with water/bicarbonate and magnesium-rich water. 
They concluded that because of the high prevalence and associated suffering 
which resulting in more health expenditures, it is imperative to conduct large 
and more rigorous trials to answer the question whether water drinking/mineral 
water can improve glycemic parameters in diabetic and non-diabetic 
individuals. (Naumann et al., 2017) 
 
3.2.5 HOT-TUB THERAPY FOR TYPE 2 DM 
Philip L. Hooper, 1999 in his study on hot-tub therapy, patients reported 
improved sleep and an increases sense of well-being during the course of study. 
It may be especially useful for the patients who are unable to do exercise. The 
benefits could result from the increased blood flow to the skeletal muscles. The 
outcome of the study suggests that hot-tub therapy should be further evaluated 
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as a therapy for patients with type 2 diabetes mellitus. (Philip L. Hooper, 
1999) 
 
3.2.6 VITAMIN E AND DIABETES MELLITUS 
Jain & Jain, 2012 in their study concluded that “Vitamin E supplementation 
has an important role in delaying the onset of the diabetic complications as well 
as for slowing down the progression of diabetic complications”. (Jain & Jain, 
2012) 
 
3.2.7 HERBAL ACUPUNCTURE AND TYPE 2 DM 
Lee et al., 2017 made a meta-analysis with seven RCTs on herbal acupuncture. 
The herbal acupuncture found to significantly reduced levels of fasting blood 
glucose, 2-hour postprandial glucose and HbA1C. However, there was no 
significant effect of herbal acupuncture on total cholesterol, HDL, LDL or 
triglyceride level. They concluded that herbal acupuncture might have a 
beneficial effect on FBG, 2-hr PPBG, and HbA1C levels in patients with Type 
2 DM.  (Lee et al., 2017) 
 
3.2.8 ACUPUNCTURE AND TYPE 2 DM 
Peplow, 2015 reported that electroacupuncture along with metformin lowers 
glucose levels and facilitates the insulin sensitivity by activating MAPK in 
steroid-induced insulin resistant rats. (Peplow, 2015) 
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Yang & Liu, 2015 observed in their study that BO’s abdominal acupuncture 
has obvious clinical efficacy for obese type-2 diabetes mellitus, featuring in 
lowering the blood pressure, reducing body weight, decreasing blood glucose, 
improving insulin sensitivity and lowering lipid level. There was no adverse 
effect reported in the study. Hence, it is worthy of clinical popularization and 
for therapeutic application. (Yang & Liu, 2015) 
 
Zhiyuan et al., 2015 in their study concluded that Acu-TENS could improve 
the health status of the diabetes patients and can be used as a therapy in clinical 
application for Type 2 Diabetes Mellitus. (Zhiyuan et al., 2015) 
 
Wang et al., 2014 reported that the acupuncture positively regulates the 
glucose and lipid metabolism in the type 2 diabetes patients. Acupuncture 
improves the insulin resistance, enhances the body’s sensitivity to insulin and 
improves the pancreatic islet beta-cell functions. (Wang et al., 2014) 
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3.2.9 YOGASANA, PRANAYAMA ON STRESS & TYPE 2 DM 
Yoga has been the subject of research for the past few decades for the 
therapeutic purposes for modern epidemic diseases like mental stress, obesity, 
hypertension, diabetes, coronary heart diseases and chronic obstructive 
pulmonary disease. Individual studies report the beneficial effect of yoga in 
these conditions, indicating that yoga can be used as non-pharmaceutical 
intervention or complement to drug therapy for treatment of these conditions. 
(Taneja, 2014) 
 
A systemic search yielded 32 articles published between 1980 and April 2007. 
These studies found that, yoga interventions are generally effective in reducing 
body weight, blood pressure, glucose level and high cholesterol. (Yang, 2007) 
It has also been postulated that yoga can rejuvenate or regenerate the β-cells of 
pancreas. (Sahay & Murthy, 1988) 
 
Malhotra et al., 2004 postulated that yoga has positive effect on general 
wellbeing, stresses, alertness and attentiveness without any side effects in an 
individual. (Malhotra et al., 2004)  
 
Sahay, 2007 observed the beneficial effect of yoga in type 2 diabetes which 
has been attributed to increased insulin sensitivity at the target tissues which 
decreases insulin resistance and consequently increases the peripheral 
utilization of glucose. (Sahay, 2007) 
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Singh et al., 2008 advocated that yoga can be considered as cost-effective and 
non-invasive adjuvant therapy. Apart from decreasing the dosage of oral 
hypoglycemic drugs or insulin, yoga can also plays vital role in delaying the 
progression of the disease process. (Singh et al., 2008) 
 
Chaya et al., 2008 reported a significant decrease in fasting plasma insulin in 
the yoga practitioners and is associated with increased insulin sensitivity and 
attenuation of negative relationship between body weight / waist circumference 
and insulin sensitivity. Yogasanas lead to increased sensitivity of β-cells of 
pancreas to the glucose signal. (Chaya et al., 2008) 
 
Any chronic disease like diabetes leads to decrease in quality of life. Poor 
quality of life may affect compliance with treatment. A randomized controlled 
trial conducted by Jyotsna et al., 2012 has shown that practice of 
comprehensive yogic breathing program significantly improves physical, 
psychological and social domains and overall total quality of life. (Jyotsna et 
al., 2012) 
 
Gopal et al., 2011 from their study concluded that yoga has significant effect 
in ameliorating the autonomic, endocrine & psychological change brought 
about by the examination stress and has a beneficial effect on the immune 
system of individual. (Gopal et al., 2011) 
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Kauts & Sharma, 2012 conducted study with 800 adolescent students; 159 
high stress students and 142 low stress students, selected on the basis of scores 
obtained through Stress Battery. Yoga module consisting of yoga asanas, 
pranayama, meditation, prayer and a value orientation programme was 
administered on experimental group for 7 weeks. Pre and post interventional 
test were conducted on both experimental and control group for their 
performance in concentration and memory tests. The result shows that the 
students who practiced yoga module yielded higher concentration levels and 
exhibited better short term memory. (Kauts & Sharma, 2012) 
 
Madanmohan et al., 2012 conducted study on the effect of yoga therapy on 
reation time, biochemical parameters and wellness score of peri and post-
menopausal diabetic patients. They concluded that six-week yoga therapy 
produces significant improvement in reaction time, blood glucose and lipid 
profile of peri- and post-menopausal diabetes subjects. They advocated that a 
comprehensive yoga therapy program has the potential to enhance the 
beneficial effects of standard medical management of diabetes mellitus, which 
can be used in an effective integrative therapy program. (Madanmohan et al., 
2012) 
 
McDermott et al., 2014 observed that, among Indians whom they are 
presented with elevated fasting blood glucose level, participation in an eight 
week yoga intervention was feasible and resulted in greater weight loss & 
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reduction in waist circumference when compared to control group. Yoga offers 
a promising lifestyle intervention for decreasing the weight-related type 2 
diabetes risk factors and potentially increasing the psychological wellbeing of 
the individual. (McDermott et al., 2014) 
 
Jyotsna et al., 2014 reported that there is a significant improvement in quality 
of life, post prandial plasma glucose and sympathetic cardiac autonomic 
function tests in patients practicing Sudarshan Kriya yoga (SKY). This 
randomized control trial points towards the beneficial effect of yogic breathing 
in preventing cardiac neuropathy progression and this has important 
implication, as cardiac autonomic neuropathy has been considered as one of the 
prime factor for the sudden cardiac deaths. (Jyotsna et al., 2014) 
 
Vinutha et al., 2015 conducted study on 15 diabetic patients to assess the 
effect of Integrated approach of Yoga Therapy (IAYT) on autonomic functions. 
This study showed a significant improvement in autonomic functions following 
1-week IAYT. They directed for further studies, needed to understand the 
autonomic changes following the long-term practice of yoga. (Vinutha et al., 
2015) 
 
Srivastava & Tiwari, 2015 investigated the effect of yoga asanas and 
pranayama on diabetic person. After eight weeks of practice, it was observed 
that asanas & pranyama reduced adults’ blood sugar level, blood pressure and 
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glycosylated hemoglobin (HbA1c); it was found at normal level. (Srivastava 
& Tiwari, 2015) 
 
Chimkod et al., 2015 in their study demonstrated that yoga is effective in 
reducing the blood glucose level in patients with type 2 diabetes mellitus. 
(Chimkod et al., 2015) 
 
A non-randomized controlled trial conducted by Dasappa et al., 2016 to study 
the effectiveness of yoga program in the management of diabetes, using the 
community health workers in the urban slums of Bangalore city revealed that 
yoga program was successful in improving their dietary practices, medication 
adherence and helpful in increasing the proportion of diabetics and 
hypertensive patients whom they maintain their parameters under control. 
(Dasappa et al., 2016) 
 
A small pilot study conducted by Mullur & Ames, 2016 reinforces the current 
medical evidence supporting the use of yoga combined with standard medical 
care to improve the health outcomes in diabetic people. (Mullur & Ames, 
2016) 
 
Gainey et al., 2016 in their experiment of the effect of Buddhist walking 
meditation on glycemic control and vascular function in patients with type 2 
diabetes, found after 12 weeks of practice that the maximal oxygen 
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consumption increased, and fasting blood glucose level decreased. Significant 
decrease in the level of HbA1C and systolic & diastolic blood pressure were 
observed in the patients practiced walking meditation. Arterial stiffness was 
improved and blood cortisol level was reduced. It has been concluded that 
Buddhist Walking meditation is superior to traditional walking program in 
patients with type 2 diabetes mellitus. (Gainey et al., 2016) 
 
Sreedevi et al., 2017 concluded that the effect of yoga and peer support on 
glycemic outcomes was incremental and recommended that longer term studies 
are necessary to ascertain the benefits shown by this feasibility study. 
(Sreedevi et al., 2017) 
 
A meta-analysis was carried out by Cui et al., 2017 to evaluate the efficacy of 
yoga in adults with type 2 diabetes mellitus. The PubMed, EMBASE and 
Cochrane database were searched to obtain eligible randomized controlled 
trials with primary outcome being FBG, secondary outcome includes HbA1C, 
total cholesterol, HDL, LDL, Triglycerides and PPBG. In their meta-analysis, 
the available data evidence suggests that yoga benefits adult patients with type 
2 diabetes mellitus; but due to limited methodology and the potential 
heterogeneity, further studies are needed to support the research findings and 
investigations were needed to find out the long-term effects of yoga in type 2 
diabetes mellitus. (Cui et al., 2017) 
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3.3 INTERVENTION 
‘Svasa’ means ‘inspiratory breath’ and ‘Prasvasa’ means ‘expiratory breath’. 
Pranayama is defined in Patanjali Yoga Sutra (chapter II-49) as “Tasmin Sati 
Svasa Prasvasayorgativicchedah Pranayamah” – Regulation of breath or 
control of Prana is the stoppage of inhalation and exhalation, which follows 
after securing that steadiness of posture or seat (Asana). Just as a goldsmith 
removes the impurities of gold by heating it in the hot furnace by strongly 
blowing the blow-pipe, in the practice of pranayama by blowing his/her lungs, 
impurities were removed from the body and Indriyas. (Sivananda, 2000) 
 
3.3.1 BHASTRIKA PRANAYAMA 
 
ऊवᲃᱧपᳯर सं᭭था᭡या शुभे पादतले उभे । 
प᳑ासनं भवेदते᭜सवᭅपापᮧणाशनम् ।। ५९ ।। 
Ūrvorupari samsthāpya śubhe pādatale ubhe | 
Padmāsanam bhavedetatsarvapāpapranāśanam || 
Meaning: Placing both soles of the feet on top of the thighs is padmasana 
which destroys all sins (bad karma). 
 
- Hatha yoga pradipika (chapter2, verse 59) 
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स᭥य᭍प᳑ासनं ब᭞᭟वा समᮕीवोदरः सुधीः । 
मुख ंसंय᭥य य᳀ेन ᮧाणं ᮖाणने रेचयेत् ।। ६० ।। 
Samyakpadmāsanam baddhvā samaghrīvodarah sudhīh | 
Mukham samyamya yatnena prānam ghrānena rechayet || 
Meaning: Sitting properly in padmasana, keeping neck and abdomen in 
alignment, exhale prana through the nose. 
 
- Hatha yoga pradipika (chapter2, verse 60) 
 
 
 
यथा लगित ᯷᭜कंठे कपालाविध स᭭वनम् । 
वेगेन पूरयेᲬािप᯷᭜प᳑ाविध माᱧतम् ।। ६१ ।। 
Yathā laghati hrtkanthe kapālāvadhi sasvanam | 
Veghena pūrayechchāpi hrtpadmāvadhi mārutam || 
 
Meaning: And again the air should be quickly inhaled upto the heart lotus. 
Accordingly, the resounding is felt from the heart and throat up to the cranium. 
 
- Hatha yoga pradipika (chapter2, verse 61) 
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पुनᳶवᭅरेचयेᱫ᳇᭜पूरयेᲬ पुनः पुनः । 
यथैव लोहकारेण भᳫा वेगेन चा᭨यते ।। ६२ ।। 
Punarvirechayettadvatpūrayechcha punah punah | 
Yathaiva lohakārena bhastrā veghena chālyate || 
 
Meaning: In that way it (the breath) is inhaled and exhaled repeatedly, with the 
same motion as a pair of bellows being pumped. 
 
- Hatha yoga pradipika (chapter2, verse 62) 
 
 
तथैव ᭭वशरीर᭭थं चालये᭜पवनं िधया । 
यदा ᮰मो भव᳎ेेह ेतदा सूयᱷण पूरयेत् ।। ६३ ।। 
Tathaiva svaśarīrastham chālayetpavanam dhiyā | 
Yadā śramo bhaveddehe tadā sūryena pūrayet || 
 
Meaning: Thus, in this way, one keeps the breath moving with mindfulness 
(awareness) and body steadiness. When the body is tired then inhale through 
the right nostril.  
 
- Hatha yoga pradipika (chapter2, verse 63) 
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यथोदरं भवे᭜पूणᭅमिनलेन तथा लघु । 
धारये ᳖ािसकां म᭟यातजᭅनी᭤यां िवना ᳃ढम् ।। ६४ ।। 
Yathodaram bhavetpūrnamanilena tathā laghu | 
Dhārayennāsikām madhyātarjanībhyām vinā drdham || 
 
Meaning: Accordingly, when the abdomen becomes full of air, then quickly 
hold the nostrils (and breath) firmly, without using the index and middle 
fingers (i.e. using the thumb and ring finger as in nasikagra mudra). 
 
- Hatha yoga pradipika (chapter2, verse 64) 
 
 
िविधव᭜कंुभकं कृ᭜वा रेचयेᳰदडयािनलम् । 
वातिपᱫशले᭬महरं शरीरािᲨिववधᭅनम् ।। ६५ ।। 
Vidhivatkumbhakam krtvā rechayedidayānillam | 
Vātapittaśleshmaharam śarīrāghnivivardhanam || 
 
Meaning: Having performed (pranayama and) retention systematically, exhale 
through the left nostril. Thereby imbalances of wind, bile and mucus are 
annihilated and the digestive fire increased. 
 
- Hatha yoga pradipika (chapter2, verse 65) 
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कंुडली बोधकं िᭃᮧं पवनं सुखद ंिहतम् ।  
ᮩᳬनाडीमुखे सं᭭थकफा᳒गᭅलनाशनम् ।। ६६ ।। 
Kundalī bodhakam kshipram pavanam sukhadam hitam | 
Brahmanādīmukhe samsthakaphādyarghalanāśanam || 
 
Meaning: This (bhastrika) quickly arouses kundalini. It is pleasant and 
beneficial, and removes obstruction due to excess mucus accumulated at the 
entrance to brahma nadi. 
 
Hatha yoga pradipika (chapter2, verse 66) 
 
 
 
स᭥य᭏गाᮢसमु᭞भूतᮕंियᮢयिवभेदकम् । 
िवशेषेणौव कतᭅ᳞ं भᳫा᭎यं कंुभकंि᭜वदम् ।। ६७ ।। 
Samyaghghātrasamudbhūtaghranthitrayavibhedakam | 
Viśeshenaiva kartavyam Bhastrākhyam kumbhakam tvidam || 
Meaning: This kumbhaka called bhastrika enables the three granthis 
(psychic/pranic knots) to be broken. Thus it is the duty of the yogi to practice 
bhastrika. 
 
Hatha yoga pradipika (chapter2, verse 67) 
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3.3.2 KAPALBHATI PRANAYAMA 
भᳫाव᭨लोहकार᭭य रेचपूरौ ससं᮪मौ । 
कपालभाितᳺवᲈ᭎याता कफदोषिवशोषणी ।। ३५ ।। 
Bhastrāvallohakārasya rechapūrau sasambhramau | 
Kapālabhātirvikhyātā kaphadoshaviśoshanī || 
 
Meaning: Perform exhalation and inhalation rapidly like the bellows (of a 
blacksmith). This is called kapalbhati and it destroys all mucous disorders. 
 
- Hatha yoga pradipika (chapter2, verse 35) 
 
 
ष᭗कमᭅिनगᭅत᭭थौ᭨यकफदोषमलाᳰदकः । 
ᮧाणायामं ततः कुयाᭅदनायासेन िस᳍यित ।। ३६ ।। 
Shatkarmanirghatasthaulyakaphadoshamalādikah | 
Prānāyāmam tatah kuryādanāyāsena siddhyati || 
 
Meaning: By the six karmas (shatkarma) one is freed from excesses of the 
doshas. Then pranayama is practiced and success is achieved without strain. 
 
- Hatha yoga pradipika (chapter2, verse 36) 
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ᮧाणायामैरेव सवᱷ ᮧशु᭬यि᭠त मला इित । 
 आचायाᭅणां  तु  केषांिचद᭠य᭜क ᭆम न संमतम् ।। ३७ ।। 
Prānāyāmaireva sarve praśushyanti malā iti | 
Āchāryānām tu keshāmchidanyatkarma na sammatam || 
 
Meaning: According to some teachers, pranayama alone removes impurities 
and therefore they hold pranayama in esteem and not the other techniques. 
 
Hatha yoga pradipika (chapter2, verse 37)  
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3.3.3 RESEARCH ON BHASTRIKA & KAPALBHATI PRANAYAMA 
Slow pace bhastrika pranayama (respiratory rate at 6/min) shows a strong 
tendency to improving the autonomic nervous system through the enhanced 
activation of parasympathetic nervous system. (Pramanik et al., 2009) 
 
M et al., 2012 reported that Bhastrika pranayama is found to be effective in 
decreasing blood pressure and increasing heart rate immediately. They found a 
significant increase in the pulmonary parameters like MEP and PEFR in their 
study. It suggests that the practice of pranayama helps in improvement of 
cardiopulmonary functions. (M et al., 2012) 
 
Patil & Sawant, 2012 observed that there was significant increase in the 
pulmonary function reflected by increase in PFT i.e. FVC, FEV, SVC, PFER & 
MVV. Lung vital capacity was found increased after the practice of bhastrika 
pranayama. It can be stated that pranayamic exercises are beneficial for better 
maintenance of pulmonary functions even in healthy individuals. (Patil & 
Sawant, 2012) 
 
Agrawal et al., 2015 found in their study that during bhastrika pranayama, 
breath holding capacity was increased near about double of its normal duration. 
The rate of exchange of air in the alveoli and ventilation at the lower areas of 
lungs increased, which increase the level of oxygen and decreases the level of 
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carbon di-oxide level in the blood, which in-turn increased the breath retention 
duration during the practice of bhastrika pranayam. (Agrawal et al., 2015) 
 
Suryawanshi et al., 2015 observed a significant increase in the pulmonary 
function test, lung vital capacity was found to increased which implies that the 
practice increase the physiological strength of the lungs and is beneficial for the 
better maintenance of the pulmonary functions. (Suryawanshi et al., 2015) 
 
Bal et al., 2009 made a study on the effect of kapalbhati on Peak Expiratory 
Flow Rate and Pulse Rate. The study was conducted on 30 female inter-college 
players of yoga from Guru Nanak Dev University, Amritsar (Punjab), INDIA. 
Six weeks kapalabhati program showed a significant improvement in peak 
expiratory flow rate and pulse rate in the individual participated in the study. 
(Bal et al., 2009) 
 
Ruhal et al., 2010 in their study of effect of kapalbhati on selected body 
composition variables reported that after 12 weeks of practice of kapalbhati, 
there was significant effect on the body fat percentage, lean body mass, body 
water content and basal metabolic rate of the individual who practiced 
kapalbhati pranayama. (Ruhal et al., 2010) 
 
Kekan,  2013 from his study concluded that body mass index and abdominal 
skinfold thickness showed a decline after the practice of kapalbhati pranayama. 
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So, Kapalbhati pranayama can be practiced regularly to reduce the obesity. 
(Kekan, 2013) 
 
Dinesh et al., 2013 concluded that a 12 weeks practice of kapalabhati 
pranyama showed improvement in the cardio-respiratory parameters with 
significant decrease in the RR, which may be attributed to a calm and stable 
mind-emotion complex. Hence, the practice of kapalabhati pranayama through 
the psychosomatic mechanism enhances the health & well-being of the 
individual. (Dinesh et al., 2013) 
 
BAL, 2015 in his study on the impact of short-term training of kapalbhati 
pranayama on components of health-related fitness found that there was a 
significant difference was found in the components of health-related fitness 
(i.e., Cardiorespiratory Endurance, Flexibility, and Percentage of body fat, Fat 
weight & Lean Body Weight). However, there was insignificant differences 
were noted in muscular strength and muscular endurance of university level 
girls with whom the study was conducted. (BAL, 2015) 
 
Jain, 2016 concluded that there was a significant improvement in 
cardiovascular and pulmonary parameters in pre-hypertensive obese subjects. 
Six weeks Kapalabhati practice normalizes the high blood pressure of pre-
hypertensive obese people; therefore it may be useful tool to keep the person 
healthy if practiced regularly throughout the life. (Jain, 2016) 
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Bal, 2016 reported that there was a significant difference in Tidal Volume (VT), 
Expiratory Reserve Volume (ERV), Vital Capacity (VC) and Inspiratory 
Capacity (IC) in the experimental group after 4-week training of kapalbhati 
pranayama. But there was insignificant difference were noted in Inspiratory 
Reserve Volume (IRV) of the subjects participated in the study. (Bal, 2016) 
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4.0 MATERIALS AND METHODS 
 
4.1 STUDY SAMPLES: 
A total number of fifty (50) subjects of both sexes within age group of 30 – 55 
years have participated in the study. The subjects were screened through a 
routine medical checkup and those who satisfy diagnostic criteria for Type 2 
Diabetes Mellitus were recruited for the study after getting informed consent. 
 
4.1.1 DESCRIPTION OF POPULATION SUBJECTED FOR STUDY 
The study population was selected from the Out Patients Department (OPD) of 
Government Yoga and Naturopathy Medical College & Hospital, 
Arumbakkam, Chennai. Based on the inclusion and exclusion criteria, those 
subjects satisfying diagnostic criteria for Type 2 Diabetes Mellitus with their 
willingness were subjected for the study. The population has fair representation 
from the rural and urban areas. The study population was from varied 
socioeconomic status particularly belonging to lower and middle 
socioeconomic groups. 
 
4.1.2 PLACE OF STUDY 
The study was conducted at Government Yoga and Naturopathy Medical 
College & Hospital - a teaching institute and a 50 bedded hospital situated at 
Chennai, catering to the needs of population from all over Tamil Nadu.  
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4.2 ETHICAL CONSIDERATION: 
4.2.1 ETHICAL CLEARANCE 
Ethical clearance for conducting the study was obtained from the Institutional 
Ethical Committee (IEC), after submitting the complete details of the research 
proposal to the committee.   
 
4.2.2 ETHICS PERTAINING TO SAMPLE SUBJECTS 
Subjects who fulfilled criteria for sample selection were explained about the 
purpose of study and provided with the information sheet containing details of 
the study viz. nature of the study, intervention used, test done for analysis of 
outcome of the study and rights of the sample being as research subject. The 
subjects have been given time and opportunity to make further clarifications. 
 
Once the subject express their interest to take part in the study they have been 
explained about the importance of their role in research study and their rights to 
withdraw anytime from the study with prior information well in advance to the 
investigator.  
 
The informed consent form with willingness details in English and Tamil 
language was given to the subjects. The subjects were asked to go through the 
consent form and they have been provided further clarifications as and when 
required. All the subjects expressed their willingness to participate in the study 
by presenting a signed informed consent form.  
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4.3 CRITERIA FOR SAMPLE SELECTION: 
4.3.1 CRITERIA FOR DIAGNOSIS 
Table 4.1 - Diagnosis of diabetes and pre-diabetes (Pearson & McCrimmon, 2014) 
Diabetes is confirmed by either: 
 Plasma glucose in random sample or 2 hrs after a 75 g glucose load ≥ 11.1 
mmol/L (200 mg/dL) or 
 Fasting plasma glucose ≥ 7.0 mmol/L (126 mg/dL)  
In asymptomatic patients, two diagnostic tests are required to confirm 
diabetes. 
Pre-diabetes is classified as 
 Impaired fasting glucose = fasting plasma glucose ≥ 6.0 mmol/L (108 
mg/dL) and < 7.0 mmol/L (126 mg/dL) 
 Impaired glucose tolerance = fasting plasma glucose < 7.0 mmol/L (126 
mg/dL) and 2-hr glucose after 75g oral glucose drink 7.8-11.1 mmol/L 
(140-200 mg/dL) 
Oral Glucose Tolerance Test (OGTT) – Venous plasma glucose 
 
Fasting 
hyperglycemia 
 
Impaired glucose 
tolerance 
 
Diabetes 
 
Fasting 
6.1-6.9 mmol/L 
(110-125 mg/dL) 
 
< 7.0 mmol/L 
(< 126 mg/dL) 
 
≥ 7.0 mmol/L 
(≥ 126 mg/dL) 
2hrs after glucose load 
< 7.8 mmol/L 
(< 140 mg/dL) 
 
7.8-11.0 mmol/L 
(140-199 mg/dL) 
 
≥ 11.1 mmol/L 
(≥ 200 mg/dL) 
 
*The use of HbA1C for diagnosis is uncertain 
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4.3.2 INCLUSION CRITERIA 
 Age group between 30 – 55 years 
 Both gender (male and female) 
 Diagnosed with type 2 diabetes mellitus. 
 On conventional medical drug therapy/complementary and 
alternative medical drug therapy for diabetes mellitus. 
 
4.3.3 EXCLUSION CRITERIA 
 Type 2 Diabetes subjects on Insulin therapy. 
 Type 1 Diabetes Mellitus (Type 1 DM) 
 Gestational Diabetes Mellitus (GDM) 
 Patients presents with associated complications of diabetes 
such as retinopathy, neuropathy, nephropathy, etc. 
 Pregnancy and lactation. 
 Obesity associated with back pain. 
 Hypertension / Arrhythmias / Ischemic Heart Disease. 
 Recent history of surgery. 
 Patients with other cardio-vascular complications, respiratory 
complaints, hernia, vertigo, and debilitating diseases. 
 Individual who already practicing yoga for a month or more. 
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4.4 STUDY DESIGN 
A prospective pre-post study design – Subjects satisfying eligibility criteria 
(Inclusion & Exclusion criteria) were selected and randomized to receive their 
intervention (either Bhastrika / Kapalbhati Pranayama). Pre- and Post-
interventional objective variable like FBS & PPBS were collected on Day 1 
and Day 30 respectively. 
 
4.4.1 SAMPLE SIZE 
Sample size (n=50).  
In both groups twenty five eligible and willing subjects i.e., Group A (n=25) 
and Group B (n=25), whom they showed their willingness to participate in the 
study by signing the informed consent, were randomized using the random 
numbers generated by the randomization method and then allocated for the 
study.  
 
4.4.2 RANDOMIZATION AND GROUPING 
Randomization was done using online team-generator tool available at the 
following link - https://www.randomlists.com/team-generator. Team A (Group 
A) was subjected to the practice of Bhastrika Pranayama and Team B (Group 
B) was subjected to the practice of Kapalbhati Pranayama, for 30 days 
respectively. 
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Figure 4.1 - Trial Profile 
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4.5 ASSESSMENT OF OBJECTIVE VARIABLE
The pre-interventional (baseline) and post
assessment of the objective variable viz. Fasting Blood Glucose (FBG) and 
Post-Prandial Blood Glucose (PPBG) were done.
 
4.5.1 ASSESSMENT INTERVAL
The pre-interventional data/baseline data is collected on day 1, before the 
selected subjects being subjected to the in
interventional/end point data were collected on the last day of the study (Day 
30) after completion of intervention. Both the baseline data and the end
data were collected from subjects of both groups (Group A and Group B) 
separately.  
 
Figure 4.2 
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4.6 INTERVENTION 
4.6.1 TEST INTERVENTION 
The selected subjects after being allocated to the specific group were properly 
trained with their specific intervention i.e. Group A subjects were trained with 
‘Bhastrika Pranayama’ and Group B subjects were trained with ‘Kapalabhati 
Pranayama’ for a week, before they are actually subjected into the study 
(Intervention Period). 
 
4.6.1.1 PROCEDURE OF TEST INTERVENTION FOR GROUP A  
Bhastrika 
Sit in a comfortable meditative pose. Keep the head and spine straight. Take a 
slow deep breath in. Breathe out quickly and forcefully through both the nostril 
but do not strain, and immediately afterwards breath in with the same force. 
(When you breath out the abdomen comes in and the diaphragm contracts. 
When you breathe in the diaphragm relaxes and the abdomen moves out. These 
movements should be slightly exaggerated) Keep the breath rhythmic, 
inhalation and exhalation must be equal. After the last exhalation, inhale 
slowly and deeply through both nostril and exhale rapidly through the mouth. 
Perform jalandhara bandha, uddiyana bandha and moola bandha in this order. 
Hold retention as long as comfortable; on completion of retention, release 
moola bandha, uddiyana bandha, and then jalandhara bandha. Between each 
round, concentrate on the natural breath or mid-eyebrow centre. Practice five 
rounds of fifty breaths. (Muktibodhananda, 2012) 
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4.6.1.2 PROCEDURE OF TEST INTERVENTION FOR GROUP B 
Kapalabhati 
Sit in a comfortable meditative pose, preferably siddhasana/siddha yoni asana. 
Close the eyes and relax, keeping the spine erect. Place the hands in either 
jnana or chin mudra. Inhale deeply and perform fifty fast respirations through 
both nostrils placing more emphasis on exhalation. Inhalation should be short. 
After the last exhalation, inhale deeply through the nose and exhale quickly 
through the mouth, slightly pursing the lips. With kumbhaka (breath holding), 
perform jalandhara bandha, moola bandha, and uddiyana bandha in this order, 
but almost simultaneously. Maintain kumbhaka and the bandhas for as long as 
possible and count the duration. Before inhaling, release moola bandha, 
uddiyana bandha and jalandhara bandha in this order. When the head is raised, 
inhale slowly through the nose. Practice five rounds of fifty breaths. 
(Muktibodhananda, 2012) 
 
4.7 DATA EXTRACTION & ANALYSIS 
4.7.1 DATA EXTRACTION 
FBG determined using the fasting blood sample and PPBG determined using 2 
hours post food intake blood sample collected using a simple finger prick 
method and the test is done using “ACCU-CHEK ACTIVE - BLOOD 
GLUCOSE MONITORING SYSTEM”. 
 
 
69 
 
4.7.2 DATA MANAGEMENT 
The collected baseline and end-point data of the outcome variable were 
managed in Microsoft Excel Sheet (Version 2007) 
 
4.7.3 DATA ANALYSIS 
The statistical analysis was done using Stats 9.0 (College, Station, Texas, 
USA). Data are expressed in mean ± standard deviation of mean. Paired‘t’ test 
were employed to analyze the intra-group outcome biochemical parameter 
(FBS & PPBS) and Two-sample ‘t’ test with equal variances were employed to 
compare inter-group means of outcome biochemical parameter (FBS & PPBS). 
For all the analysis, 95% confidence intervals is used and the ‘p’ value <0.05 is 
considered to be as statistically significant.  
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5.0 RESULT 
 
The present study was conducted to compare and evaluate the efficacy of bhastrika 
and kapalbhati pranayama in the management of type 2 diabetes mellitus. The 
efficacies of the interventions were assessed based on the outcome variable viz. 
Fasting Blood Sugar (FBS) and 2-hour Post-Prandial Blood Sugar (2-hrPPBS). For all 
the statistical analysis 95% confidence interval is used and the ‘p’ value < 0.05 is 
considered to be as statistically significant. 
 
The extracted baseline and end-point data were analyzed using, paired‘t’ test to 
evaluate the outcome within the group and the two-sample ‘t’ test with equal 
variances to compare and evaluate the outcome of the intervention between the group. 
In a Paired‘t’ test employed, the following variables of Group A, FBS (p<0.0001) 
(t=39.19), 2-hr PPBS (p<0.0001) (t=42.2) and the variables of Group B, FBS 
(p<0.001) (t=35.38), 2-hr PPBS (p<0.001) (t=19.46) shows a statistically significant 
change. 
 
Meanwhile, in a Two-sample‘t’ test with equal variances (difference in FBS [fbspre-
fbspost] and PPBS [ppbspre-ppbspost]) employed between the groups, the following 
variable FBS (p<0.0001) (t=9.69) and 2-hr PPBS (p<0.0001) (t=12.18) shows a 
statistically significant change.  
 
 
Fig 5.1 (a) - Sex distribution in Group A
 
 
 
Fig 5.1 (b) - Sex distribution in Group B
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Table 5.1 – Effect of Bhastrika pranyama on Fasting Blood Sugar (FBS) and 2-hr 
Post-Prandial Blood Sugar (PPBS) in Type 2 Diabetes Mellitus 
 
 
 
 
Variables 
 
Group A 
 
 
 
p Value 
 
Mean ± S.D. 
 
Pre 
 
Post 
 
Fasting Blood Sugar 
(FBS) 
 
 
 
177.4 ± 29.57 
 
 
143.32 ± 26.49 
 
 
0.001 
 
2-hr Post-Prandial 
Blood Sugar 
(PPBS) 
 
 
 
229.52 ± 25.76 
 
 
 
196.68 ± 25.79 
 
 
0.001 
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Table 5.2 - Effect of Kapalbhati pranyama on Fasting Blood Sugar (FBS) and 2-
hr Post-Prandial Blood Sugar (PPBS) in Type 2 Diabetes Mellitus 
 
 
 
 
Variables 
 
Group B 
 
 
 
p Value 
 
Mean ± S.D. 
 
Pre 
 
Post 
 
Fasting Blood Sugar 
(FBS) 
 
 
 
180.2 ± 20.56 
 
 
156.72 ± 21.06 
 
 
0.001 
 
2-hr Post-Prandial 
Blood Sugar 
(PPBS) 
 
 
 
225.36 ± 22.76 
 
 
207.28 ± 24.72 
 
 
0.001 
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Fig 5.2 – Effect of Bhastrika Pranayama on Fasting Blood Sugar 
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Fig 5.3 – Effect of Kapalbhati Pranayama on Fasting Blood Sugar 
 
Pr
e
Po
st
 
 
 
75 
 
Fig 5.4 – Effect of Bhastrika Pranayama on Post-Prandial Blood Sugar 
 
 
 
 
Fig 5.5 – Effect of Kapalbhati Pranayama on Post-Prandial Blood Sugar 
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Table 5.3 – Comparison of the difference in Fasting Blood Sugar (fbspre-fbspost) 
and 2hr Post-Prandial Blood Sugar (ppbspre-ppbspost) between the Group A 
and Group B  
 
 
Variables 
 
Group 
 
Mean ± S.D. 
 
p Value 
 
 
Fasting Blood 
Sugar (FBS) 
 
 
Bhastrika 
 
 
34.08 ± 4.35 
 
 
 
0.001  
Kapalbhati 
 
 
23.48 ± 3.32 
 
2-hr Post-
Prandial Blood 
Sugar 
(PPBS) 
 
 
Bhastrika 
 
 
32.84 ± 3.89 
 
 
 
0.001  
Kapalbhati 
 
 
18.08 ± 4.65 
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Fig. 5.6 
 
 
 
Fig. 5.7 
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6.0 DISCUSSION 
 
Psychological and physical stresses play a significant role in the development of the 
hyperglycemia, in the setting of type 2 diabetes mellitus. (Batch & Surwit, 2008) 
Although the human studies on the role of stress in the development and course of 
type 2 diabetes mellitus are few, a large number of animal studies supports that stress 
reliably produces hyperglycemia. Furthermore, there is a mounting evidence of the 
autonomic contributions to the pathophysiology of diabetes mellitus both in animals 
and in humans. (Surwit et al., 1992) Many of the modern researches and the goal of 
management in conventional medicine focus mainly on the various mechanism, 
chemical mediators and the genes which helps to promote insulin secretion / sensitize 
the insulin or those substance which bring down the glucose nearly normal levels. 
There are very few or at times no importance has been given for the psychological 
dimension of the patients suffering with diabetes mellitus, which has a strong 
influence on the hormones and endocrine functions through Psycho-neuro-endocrine-
immune mechanism. 
 
Yoga works on all aspects of the human viz. physical, vital, mental, emotional, 
psychic and spiritual planes. (Saraswati, 2009) Yoga has been shown to have effects 
on most physiological systems of the body. Among the various biochemical effects of 
yoga, a decrease in cortisol levels and control of glucose levels in diabetic subjects 
have been reported. (Gopal et al., 2011) Earlier studies in yoga have showed the 
importance and role of yoga in stress management, diabetes management in separate; 
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but there is a scanty information or study about the management of diabetes through 
stress control. 
 
Pranayama has its effect not only on the breathing mechanism but also on other organs 
of the body. While practicing vigorous pranayama (fast breathing technique), the mind 
becomes inactive and tranquil for some time. By practicing retention of breath, mind 
becomes relaxed and there is no other way to bringing about relaxation of mind 
because thoughts always continuous to come in mind. (Saraswati, 2002) 
 
The present study was done to evaluate and compare the outcome of the practice of 
Bhastrika and Kapalbhati pranayama (fast breathing technique) for five weeks in 
patients with type 2 diabetes mellitus. A statistically significant change was observed 
in the biochemical parameters (outcome variable) viz. Fasting Blood Sugar and Post-
Prandial Blood Sugar in both the groups which implies both the pranayama were 
effective in reducing the blood glucose level (within nearly normal limits). While, 
comparing the difference in the fasting and post-prandial blood sugar (diff fbs = 
fbspre-fbspost; diff ppbs = ppbspre-ppbspost) of both the groups, Group A (Bhastrika) 
subjects showed a better reduction both in fasting as well as post-prandial blood sugar 
level compared to that of the Group B (Kapalbhati) subjects. 
 
The observed significant changes in the biochemical parameters showed decreasing 
trend in mean values of pre and post FBS & PPBS of both the groups whereas when 
the mean of the end point data of the biochemical parameters [mean FBS (end point) 
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of Group A & mean of the FBS (end point), mean PPBS (end point) of Group A & 
mean PPBS (end point) of Group B] are subjected to two-sample ‘t’ test, the statistical 
significant change was not observed probably due to less sample size and less duration 
of intervention. Hence longer duration of the study may be conducted with more 
number of the samples to observe the outcome. 
 
A literature review was made by Singh VP et al, 2005 to understand interrelated 
psycho-Neuro-Endocrine and Immunological mechanism of action of yoga in Type 2 
Diabetes Mellitus. The published literature concerning mechanisms of action of Yoga 
in Type 2 diabetes mellitus emphasizing psycho-neuro-endocrine or immunological 
relations was retrieved from Pubmed. The postulated mechanism of action of yoga is 
through parasympathetic activation and anti-stress mechanism. Yoga reduces the 
perceived stress and hypothalamic-pituitary-adrenal axis (HPA axis) activation, 
thereby improving the overall metabolic and psychological profiles, viz. increasing 
insulin sensitivity, improving glucose tolerance and lipid metabolism. (Singh et al., 
2015) 
 
Pal et al., 2004 conducted a study to find out the effect of short-term practice (3 
months) of breathing exercise on autonomic functions in normal healthy volunteers. A 
total of 60 male undergraduate students were randomly divided into two groups: slow 
breathing group and fast breathing group. They observed that there was increased 
parasympathetic activity and decreased sympathetic activity in slow breathing group 
whereas no significant change in group practiced fast breathing. (Pal et al., 2004)  
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In a study conducted by Jyotsna et al., 2013 randomized 120 patients either to 
standard diabetic care or to a yogic breathing program for 6 months. At the end of the 
study, quality of life and post prandial plasma glucose level have significantly 
improved in the group practicing yoga, compared with baseline value, but there was 
no significant improvement in fasting plasma glucose level and HbA1c. (Jyotsna et 
al., 2013) While, our present study has showed the improvement both in fasting and 
post-prandial blood glucose level in both group of subjects (Group A & Group B) 
practiced fast breathing technique. 
 
In a previous study conducted by Thangavel et al., 2014 to evaluate the effect of 12 
weeks training of slow and fast pranayama on handgrip strength and endurance in 
young healthy volunteers of JIPMER population, they observed a significant change 
only in hand grip endurance (HE) in slow pranyama group whereas significant 
improvement in hand grip strength (HGS) as well as endurance (HGE) in fast 
pranayama group. They concluded that pranayama training decreases sympathetic 
activity resulting in mental relaxation and decreased autonomic arousal, and thereby 
decreasing force fluctuation during isometric concentration. (Thangavel et al., 2014)  
 
In another interesting study conducted by Shende et al., 2013 short-term intervention 
of pranayama on blood glucose level in medical students, they noticed a significant 
reduction in stress in medical students which in turn improved both fasting and post 
meal blood glucose level. (Shende et al., 2013) Equivalently our present study also 
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demonstrated a significant reduction in both fasting and post prandial blood glucose 
level in diabetic subjects of both groups (Group A & Group B). 
 
Altogether, the practice of Bhastrika as well as Kapalbhati pranayama among type 2 
diabetic subjects showed, a significant reduction in fasting- as well as post-prandial 
blood sugar level which might have been resulted due to a decreased sympathetic 
activity and improved parasympathethic activity via tranquil effect and stress 
curtailment induced by the pranayama practice as postulated in the previous research 
studies. Further, from the difference in the fasting and post-prandial blood sugar level 
of group A and group B, it is inferred that the practice of bhastrika pranayama is more 
effective in reducing the blood sugar level than kapalbhati pranayama in a short-term 
practice. However, the study of longer duration, with large number of sample is 
necessary to reaffirm the assertion. 
 
6.1 STRENGTH OF STUDY 
The following were the strength of our present study: 
 Effective randomization 
 Equally distributed group of subjects 
 No dropouts in study 
 Significant improvement in outcome variables 
 No adverse reaction occurred during study 
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6.2 LIMITATION AND DRAWBACKS 
 Smaller sample size 
 Short duration of intervention 
 Stress tool is not used for study 
 Blinding was not possible 
 Subjects were not on strict and uniform diet plan 
 Other naturopathy treatments might have had its influence on the outcome 
variable 
 
6.3 FUTURE PROSPECTS 
 A study with larger sample, longer duration with stress tool may be needed to 
substantiate the results of the present study 
 Further study at the molecular level may be done to study the effect of 
pranayama on the neuro-endocrine-immune mechanism. 
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7.0 CONCLUSION 
 
The present study demonstrated that 5 weeks practice of both bhastrika as well as 
kapalbhati pranayama is efficacious in reducing the fasting as well as post-prandial 
blood sugar level in type 2 diabetic subjects. From the difference in fasting and post-
prandial blood sugar of both groups, it is inferred that the practice of bhastrika 
pranayama is more effective than kapalbhati pranayama in reducing the blood sugar 
level in a short-term practice which might have been the resultant effect of decreased 
sympathetic activity, increased parasympathetic activity and improved insulin 
sensitivity in patients with type 2 diabetes mellitus, as postulated in earlier studies. 
However, the study of longer duration with large number of sample with stress as tool 
is necessary to reaffirm the assertion. 
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8.0 SUMMARY 
 
Diabetes is no longer a disease of rich nation; rather it is on rise everywhere most 
predominantly in low- and middle-income countries. It is difficult to define or 
measure the role of stress in the etiology of diabetes, but there is significant evidence 
suggest of stress’s’ metabolic consequences in an individual who already suffering 
from chronic disease like diabetes mellitus. Yoga is a mind-body technique being 
holistic in nature; it is the best means for achieving physical, mental, social and 
spiritual well being. Pranayama (breathing exercises) appear to alter autonomic, 
responses to breathe holding. 
 
The present study was done to evaluate the effect of Bhastrika and Kapalbhati 
Pranayama on blood glucose level in subjects with type 2 diabetes mellitus. Fifty type 
2 diabetes subjects whom they were on either conventional medical therapy or herbal 
medical therapy were screened and recruited from the out-patients department (OPD) 
of Government Yoga and Naturopathy Medical College & Hospital, Chennai. The 
recruited subjects were randomized using computerized random numbers, thus 
resulting in (n=25) Group A and (n=25) in Group B. Group A was subjected to the 
practice of Bhastrika Pranayama and Group B was subjected to the practice of 
Kapalbhati Pranayama for the period of five weeks. 
 
 
86 
 
The assessment variables include pre- and post-interventional fasting blood glucose 
and post-prandial blood glucose level. Baseline data was collected on Day 1 before 
subjecting the selected subjects in to the intervention and the end-point data was 
collected on the day 30 i.e., on the last day of the intervention after the subject finishes 
their concerned intervention. The collected data were properly maintained for the 
statistical analysis. 
 
Statistical Analysis was done with Stats 9.0 (College, Station, Texas, USA). Paired‘t’ 
test were employed to analyze the intra-group outcome biochemical parameter Fasting 
Blood Sugar (FBS) and Post-Prandial Blood Sugar (PPBS) and Two-sample ‘t’ test 
with equal variances were employed to compare inter-group means of outcome 
biochemical parameter (FBS & PPBS). The statistical analysis has shown a significant 
change in the biochemical parameters of the subjects of both the group (Group A & 
Group B). Hence, this study has shown that the short-term practice of Bhastrika as 
well as Kapalbhati Pranayama were potent in decreasing the fasting- and post-prandial 
blood sugar level in type 2 diabetes mellitus patients possibly by increasing the vagal 
tone and decreasing the sympathetic discharge, wherein enhances the parasympathetic 
activity which positively influence stress, insulin resistance, obesity and sedentary 
lifestyle, which are the risk factors of diabetes mellitus. 
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Annexure 1: PROFORMA 
 
 
Name:        Age:   
 
Gender: Male / Female     Marital Status: 
 
Religion:       Occupation: 
 
Address: 
 
 
Emergency Contact:      Primary Language(s): 
 
 
 
Complaints: 
 
 
 
 
 
History of present Illness: 
 
 
 
Previous Illness: 
 
 
 
Personal History: 
 
Diet:     Appetite:    Digestion: 
 
Sleep:     Micturition:    Bowel: 
 
Coffee/Tea:  with/without sugar     Addiction: 
 
 
Family History: 
 
 
 
Treatment History: 
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History of Allergy to any specific drugs/food, if any: 
 
 
Obstetrics & Gynecology history: 
 
 
Vital data: 
 
Height: cms    Weight:   kg  
  
Pulse:  beats/min   Blood Pressure:  mm/Hg 
 
BMI:      Waist Hip ratio: 
 
Built:      Temperature: 
 
 
GENERAL PHYSICAL EXAMINATION: 
 
 
    
 
SYSTEMIC EXAMINATION: 
 
Cardiovascular System: 
 
 
Respiratory System: 
 
 
Abdomen: 
 
 
Nervous System: 
 
 
Endocrine System: 
 
 
Genitourinary System: 
 
 
Locomotor System: 
 
 
Investigation: 
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Annexure 2: INFORMATION SHEET 
We are conducting a study “Evaluation of the effect of Bhastrika and Kapalbhati 
Pranayama on blood glucose level in Type 2 Diabetes Mellitus” at Government 
Yoga and Naturopathy Medical College and Hospital, Chennai – 106. The purpose of 
this study is to evaluate the effect of pranayama (Yogic Breathing Exercise) on blood 
glucose level in Type 2 Diabetes Mellitus, which may be of use in better management 
of Diabetes Mellitus in future. 
We need your participation in this study. Here we are assessing the changes in the 
blood glucose level by measuring the pre- and post interventional, Fasting and 2-hr 
Post-Prandial blood glucose levels. 
The privacy of the patients in the research will be maintained throughout the study. In 
the event of any publication or presentation resulting from the research, no personally 
identifiable information will be shared. 
Taking part in this study is voluntary. You are free to decide whether to participate in 
this study or to withdraw at any time; your decision will not result in any loss of 
benefit to which you are otherwise entitled. The results of the special study may be 
intimated to you at the end of the study period or during the study if anything is found 
abnormal which may aid in the management or treatment. 
 
Signature of investigator                   Signature of participant 
Date: 
107 
 
Annexure 3: INFORMED CONSENT FORM 
Title of the study: Evaluation of the effect of Bhastrika and Kapalbhati 
Pranayama on blood glucose level in Type 2 Diabetes Mellitus 
Name of the Participant:  
Name of the Principal Investigator: Dr. Varun. V 
Name of the Institution: Department of Yoga, 
Government Yoga and Naturopathy Medical College and Hospital, 
Chennai - 106 
Documentation of the informed consent 
I _____________________________ have read the information in this form (or it has 
been read to me). I was free to ask any questions and they have been answered. I am 
over 18 years of age and, exercising my free power of choice, hereby give my consent 
to be included as a participant in “Evaluation of the effect of Bhastrika and 
Kapalbhati Pranayama on blood glucose level in Type 2 Diabetes Mellitus” 
1. I have read and understood this consent form and the information provided to 
me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the investigator. 
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5. I have been informed the investigator of all the treatments I am taking or have 
taken in the past ________ months including any native (alternative) treatment. 
6. I have been advised about the risks associated with my participation in this 
study. 
7. I agree to cooperate with the investigator and I will inform him/her 
immediately if I suffer unusual symptoms.  
8. I have not participated in any research study within the past 
_________month(s).  
9. I am aware of the fact that I can opt out of the study at any time without having 
to give any reason and this will not affect my future treatment in this hospital.  
10. I am also aware that the investigator may terminate my participation in the 
study at any time, for any reason, without my consent.  
11. I hereby give permission to the investigators to release the information 
obtained from me as result of participation in this study to the sponsors, 
regulatory authorities, Govt. agencies, and IEC. I understand that they are 
publicly presented. 
12. I have understood that my identity will be kept confidential if my data are 
publicly presented. 
13. I have had my questions answered to my satisfaction. 
14. I have decided to be in the research study. 
I am aware that if I have any question during this study, I should contact the 
investigator. By signing this consent form I attest that the information given in this 
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document has been clearly explained to me and understood by me, I will be given a 
copy of this consent document. 
For adult participants: 
Name and signature / thumb impression of the participant (or legal 
representative if participant incompetent) 
Name _________________________   Signature_________________  
Date________________ 
Name and Signature of impartial witness (required for illiterate patients): 
Name _________________________   Signature_________________  
Date________________ 
Address and contact number of the impartial witness: 
 
 
Name and Signature of the investigator or his representative obtaining consent: 
Name _________________________   Signature_________________  
Date________________ 
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Annexure 4: INFORMATION TO PARTICIPANTS 
Investigator:  Dr. Varun. V 
Name of Participant: 
Title: Evaluation of the effect of Bhastrika and Kapalbhati Pranayama on blood 
glucose level in Type 2 Diabetes Mellitus 
You are invited to take part in this research/ study /procedures. The information in this 
document is meant to help you decide whether or not to take part. Please feel free to 
ask if you have any queries or concerns. You are being asked to participate in this 
study being conducted in department of Yoga, Government Yoga and Naturopathy 
Medical College and Hospital, Chennai – 600 106 
What is the Purpose of the Research? 
To evaluate and compare the effects of Bhastrika and Kapalbhati Pranayama (Yogic 
Breathing Exercise) on blood glucose level in Type 2 Diabetes Mellitus 
The Study Design 
Fifty, Type 2 Diabetes Mellitus patients of age group between 30-55 yrs will 
participate in the study.  
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Study Procedures 
The study involves assessment of pre- and post interventional, Fasting & 2-hr Post-
Prandial blood glucose level. The test involves simple finger prick blood glucose 
analysis.  
You will be required to visit the hospital during the study. You may have to come to 
the hospital (study site) for examination and investigations apart from your scheduled 
visits, if required. 
Possible Risks to you 
Nil 
Possible benefits to you 
Blood glucose level were tested free of cost thereby proper intervention can be 
implemented. 
Possible benefits to other people 
The result of the research may provide benefits to the society in terms of advancement 
of medical knowledge and/or therapeutic benefits to future patients.  
Confidentiality of the information obtained from you 
You have the right to confidentiality regarding the privacy of your medical 
information (personal details, results of physical examinations, investigations, and 
your medical history). By signing this document, you will be allowing the research 
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team investigators, other study personnel, sponsors, IEC and any person or agency 
required by law like the Drug Controller General of India to view your data, if 
required. 
The information from this study, if published in scientific journals or presented at 
scientific meetings, will not reveal your identity. 
How will your decision to not participate in the study affect you? 
Your decisions to not to participate in this research study will not affect your medical 
care or your relationship with investigator or the institution. Your doctor will still take 
care of you and you will not lose any benefits to which you are entitled. 
Can you decide to stop participating in the study once you start? 
The participation in this research is purely voluntary and you have the right to 
withdraw from this study at any time during course of the study without giving any 
reasons. 
However, it is advisable that you talk to the research team prior to stopping the 
treatment 
 
 
